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SCIENTIFIC OPINION  
Scientific Opinion on Flavouring Group Evaluation 3, Revision 2 
(FGE.03Rev2): 
Acetals of branched- and straight-chain aliphatic saturated primary 
alcohols and branched- and straight-chain saturated or unsaturated 
aldehydes, an ester of a hemiacetal and an orthoester of formic acid, from 
chemical groups 1, 2 and 4 1 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3  
ABSTRACT 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European 
Food Safety Authority was requested to evaluate one flavouring substance, acetaldehyde ethyl 
isopropyl acetal [FL-no: 06.137], structurally related to the 58 flavouring substances in the Flavouring 
Group Evaluation 03, in a Revision 2, using the Procedure in Commission Regulation (EC) No 
1565/2000. None of the substances were considered to have genotoxic potential. The new substance 
was along with the remaining 58 substances evaluated through a stepwise approach (the Procedure) 
that integrates information on structure-activity relationships, intake from current uses, toxicological 
threshold of concern, and available data on metabolism and toxicity. The Panel concluded as for the 
other already evaluated substances that the substance [FL-no: 06.137] do not give rise to safety 
concern at its level of dietary intake, estimated on the basis of the MSDI approach. Besides the safety 
assessment of this flavouring substance, the specifications for the materials of commerce have also 
been considered, and since the publication of FGE.03Rev1 additional information on chirality on 30 
substances is made available and has been incorporated into the present Revision 2 of FGE.03. 
© European Food Safety Authority, 2011 
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SUMMARY 
The European Food Safety Authority (EFSA) asked the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (the Panel) to provide scientific advice to the Commission on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was requested to evaluate 59 flavouring substances in the 
Flavouring Group Evaluation 03, Revision 2 (FGE.03Rev2), using the Procedure as referred to in the 
Commission Regulation (EC) No 1565/2000. These 59 flavouring substances belong to chemical 
groups 1, 2 and 4, Annex I of the Commission Regulation (EC) No 1565/2000. 
The present Flavouring Group Evaluation deals with 57 acetals of branched- and straight-chain 
aliphatic saturated primary alcohols and branched- and straight-chain saturated or unsaturated 
aldehydes, one orthoester of formic acid and one ester of a hemiacetal.  
Thirty-three of the 59 flavouring substances possess one or more chiral centres. For all of these 
substances the stereoisomeric composition has been specified.  
One of the 59 substances can exist as a geometrical isomer [FL-no: 06.063] and no indication has been 
given that one of the possible isomers has preponderance in the commercial flavouring material. 
Fifty-eigth of the flavouring substances are classified into structural class I and the orthoester [FL-no: 
06.096] into structural class III. 
Forty-three of the substances in the present group of 59 substances have been reported to occur 
naturally in a wide range of food items.  
In its evaluation, the Panel as a default used the “Maximised Survey-derived Daily Intakes” (MSDIs) 
approach to estimate the per capita intakes of the flavouring substances in Europe. However, when the 
Panel examined the information provided by the European Flavouring Industry on the use levels in 
various foods, it appeared obvious that the MSDI approach in a number of cases would grossly 
underestimate the intake by regular consumers of products flavoured at the use level reported by the 
Industry, especially in those cases where the annual production values were reported to be small. In 
consequence, the Panel had reservations about the data on use and use levels provided and the intake 
estimates obtained by the MSDI approach.  
In the absence of more precise information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a “modified Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. In those cases where the 
mTAMDI approach indicated that the intake of a flavouring substance might exceed its corresponding 
threshold of concern, the Panel decided not to carry out a formal safety assessment using the 
Procedure. In these cases the Panel requires more precise data on use and use levels. 
According to the default MSDI approach, the 59 flavouring substances have intakes in Europe from 
0.001 to 14 microgram/capita/day, which are below the threshold of concern value for structural class 
I of 1800 microgram/person/day. Likewise the estimated level of intake for the orthoester [FL-no: 
06.096] of 0.013 microgram/capita/day is below the threshold of concern for structural class III of 90 
microgram/person/day.  
Adequately reported genotoxicity studies are only available for one of the flavouring substances. 
These studies do not give rise to safety concern with respect to genotoxicity of the flavouring 
substance in this Flavouring Group Evaluation. Consideration was given to methanol, formaldehyde, 
ethanol and acetaldehyde that are potential hydrolysis products of several of the acetals in the present 
Flavouring Group Evaluation. Because of the natural occurrence in food and the endogenous 
formation in humans of considerably larger amounts of these compounds, their formation from 
Flavouring Group Evaluation 3, Revision 2
 
 
3 EFSA Journal 2011; 9(10):2312 
hydrolysis of the acetals were not considered to be of safety concern with respect to genotoxicity at 
their estimated levels of intakes, based on the MSDI approach. 
The 59 candidate substances are expected to be metabolised to innocuous products. 
There are no toxicological studies available on the 59 flavouring substances or on structurally related 
acetals other than data on acute toxicity.  
On the basis of the default MSDI approach the Panel concluded that the 57 acetals, the orthoester and 
the ester of a hemiacetal would not give rise to safety concerns at levels of intake arising from their 
use as flavouring substances.  
When the estimated intakes were based on the mTAMDI approach they ranged from 3 to 9500 
microgram/person/day for the 58 substances from structural class I. For 16 of the substances the 
intakes were above the threshold of concern for structural class I of 1800 microgram/person/day. For 
the one substance from structural class III [FL-no: 06.096] the mTAMDI is 1600 
microgram/person/day, which is above the threshold of concern for structural class III of 90 
microgram/person/day.  
Thus, for 17 of the 59 flavouring substances considered in this Opinion, the intakes, estimated on the 
basis of the mTAMDI, exceed the relevant threshold for their structural class to which the flavouring 
substance has been assigned. Therefore, for these 17 substances more reliable exposure data are 
required. On the basis of such additional data, these flavouring substances should be reconsidered 
using the Procedure. Subsequently, additional data might become necessary. 
In order to determine whether this evaluation could be applied to the materials of commerce, it is 
necessary to consider the available specifications. Adequate specifications including complete purity 
criteria and identity tests for the materials of commerce have been provided for 42 of the 59 flavouring 
candidate substances. The specifications are not adequate for 17 substances [FL-no: 03.023, 06.041, 
06.042, 06.043, 06.045, 06.046, 06.047, 06.063, 06.105, 06.106, 06.107, 06.109, 06.115, 06.123, 
06.124, 06.128 and 06.129] as identity tests are lacking and for one of substances [FL-no: 06.063] has 
the stereoisomeric composition to be specified. Thus, the final evaluation of the materials of commerce 
cannot be performed for 17 substances ([FL-no: 03.023, 06.041, 06.042, 06.043, 06.045, 06.046, 
06.047, 06.063, 06.105, 06.106, 06.107, 06.109, 06.115, 06.123, 06.124, 06.128, 06.129]), pending 
further information.  
For the remaining 42 substances [FL-no: 06.044, 06.048, 06.049, 06.050, 06.051, 06.052, 06.053, 
06.054, 06.055, 06.057, 06.058, 06.059, 06.061, 06.062, 06.064, 06.065, 06.066, 06.067, 06.069, 
06.070, 06.071, 06.073, 06.074, 06.075, 06.076, 06.079, 06.082, 06.083, 06.084, 06.085, 06.086, 
06.091, 06.092, 06.096, 06.100, 06.111, 06.114, 06.125, 06.127, 06.130, 06.131 and 06.137] the Panel 
concluded that they would present no safety concern at the levels of intake estimated on the basis of 
the MSDI approach. 
KEY WORDS 
Straight-chain; branched-chain; acetals; saturated; acyclic; primary alcohols; aldehydes; orthoester; 
formic acid; flavourings; safety; FGE.03.     
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002b).  
The FGE is revised to include substances for which data were submitted after the deadline as laid 
down in Commission Regulation (EC) No 622/2002 and to take into account additional information 
that has been made available since the previous Opinion on this FGE.  
The Revision also includes newly notified substances belonging to the same chemical groups 
evaluated in this FGE. 
After the completion of the evaluation programme the Union List of flavouring substances for use in 
or on foods in the EU shall be adopted (Article 5 (1) of Regulation (EC) No 2232/96) (EC, 1996a). 
HISTORY OF THE EVALUATION 
FGE Opinion 
adopted by 
EFSA 
Link No. of 
candidate 
substances 
FGE.03 7 October 
2004 
http://www.efsa.eu.int/science/afc/afc_opinions/671_en.html 42 
FGE.03Rev1 18 April 
2007 
http://www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178689852831.htm 
58 
FGE.03Rev2 6 July 2011  59 
 
The present revision of FGE.03, FGE.03Rev2, includes the assessment of one additional candidate 
substance, acetaldehyde ethyl isopropyl acetal, [FL-no: 06.137]. No new toxicity or metabolism data 
were available for this substance However, the Panel is aware of the BfR discussion4 on acetaldehyde 
(which is the hydrolysis product of [FL-no: 06.137]. A search in open literature did not reveal any 
relevant information for [FL-no: 06.137].  
Since the publication of FGE.03Rev1 additional information on geometrical isomerism / chirality on 
30 substances is made available and has been incorporated into the present FGE (EFFA, 2010a).  
Furthermore, the Industry has submitted data to support the change of structural class from Cramer 
Class III to II for triethoxymethane [FL-no: 06.096] (EFFA, 2011a). 
                                                     
 
4http://www.bfr.bund.de/cm/343/5_sitzung_der_bfr_kommission_fuer_lebensmittelzusatzstoffe_aromastoffe_un
d_verarbeitungshilfsstoffe.pdf 
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TERMS OF REFERENCE 
The European Food Safety Authority (EFSA) is requested to carry out a risk assessment on flavouring 
substances in the Register prior to their authorisation and inclusion in a Union List according to 
Commission Regulation (EC) No 1565/2000 (EC, 2000a). In addition, the Commission requested 
EFSA to evaluate newly notified flavouring substances, where possible, before finalising the 
evaluation programme. The evaluation programme was finalised by 31 December 2009. 
In addition, in letter of 18 March 2011 the Commission requested EFSA to carry out a risk assessment 
on acetaldehyde ethyl isopropyl acetal [FL-no: 06.137] in accordance with Commission Regulation 
(EC) No 1565/2000 (EC, 2000a) by 31 December 2011. 
ASSESSMENT 
1. Presentation of the Substances in Flavouring Group Evaluation 3, Revision 2 
1.1. Description 
The present Flavouring Group Evaluation 3, Revision 2 (FGE.03Rev2) using the procedure as referred 
to in the Commission Regulation (EC) No 1565/2000 (EC, 2000a) (the Procedure - shown in 
schematic form in Annex I), deals with 59 acetals of branched- and straight-chain aliphatic saturated 
primary alcohols and branched- and straight-chain saturated or unsaturated aldehydes, one orthoester 
of formic acid and one ester of a hemiacetal. These 59 flavouring substances (candidate substances) 
belong to chemical groups 1, 2 and 4, Annex I of the Commission Regulation EC No 1565/2000 (EC, 
2000a). 
The 59 candidate substances under consideration, with their chemical Register names, FLAVIS- (FL-), 
Chemical Abstract Service- (CAS-), Council of Europe- (CoE-) and Flavor and Extract Manufactures 
Association- (FEMA-) numbers, structure and specifications, are listed in Table 1. 
The 59 candidate substances are closely related structurally to ten acetals (supporting substances) 
evaluated at the 57th JECFA meeting (JECFA, 2002a) as well as to two acetals (supporting substances) 
evaluated by the Council of Europe (CoE, 1992).  
The flavouring substances under consideration in the present evaluation are listed in Tables 1 and 2a, 
the hydrolysis products of the candidate substances are listed in Table 2b, and the supporting 
substances are listed in Table 3. 
1.2. Stereoisomers 
It is recognised that geometrical and optical isomers of substances may have different properties. Their 
flavour may be different, they may have different chemical properties resulting in possible variability 
in their absorption, distribution, metabolism, elimination and toxicity. Thus, information must be 
provided on the configuration of the flavouring substance, i.e. whether it is one of the 
geometrical/optical isomers, or a defined mixture of stereoisomers. The available specifications of 
purity will be considered in order to determine whether the safety evaluation carried out for candidate 
substances for which stereoisomers may exist can be applied to the material of commerce. Flavouring 
substances with different configurations should have individual chemical names and codes (CAS 
number, FLAVIS number etc.). 
Thirty-three of the 59 substances possess a chiral centre. In most of these cases, the chirality results 
solely because the acetal is asymmetric, i.e. it is formed from an aldehyde and two different alcohols, 
none of which contains a chiral centre [FL-no: 03.023, 06.041, 06.042, 06.043, 06.044, 06.045, 
06.046, 06.047, 06.048, 06.050, 06.082, 06.083, 06.084, 06.085, 06.086, 06.091, 06.092, 06.111, 
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06.114, 06.115, 06.123, 06.127, 06.128, 06.129, 06.130, 06.131 and 06.137]. In these cases, the 
Industry has informed that all these acetal derivatives occur as their mixtures of optical isomers (of the 
acetal moiety), i.e. as the racemates (EFFA, 2010a; Flavour Industry, 2011c). This new information 
has implications for two of the substances in the present FGE, [FL-no: 06.043 and 06.127], as the 
Industry has informed that both are racemic mixtures of isomers and they then turned out to be 
identical substances. For three substances either the aldehyde [FL-no: 06.057 and 06.109] or the 
alcohol moiety [FL-no: 06.051] contain one chiral centre. According to the information provided [FL-
no: 06.051, 06.057 and 06.109] are used as a racemic mixture (EFFA, 2001a; EFFA, 2001b; EFFA, 
2001c; EFFA, 2010a). Three of the substances [FL-no: 06.049, 06.079 and 06.107] have one chiral 
centre in the aldehyde moiety and one in the alcohol moiety. According to the information provided by 
Industry since the publication of FGE.03Rev1, both the alcohol and the aldehyde moiety occur as their 
racemic mixtures (mixtures of R- and S-enantiomers) (EFFA, 2010a). 
Due to the presence and the position of a double bond, one of the 59 substances can exist as 
geometrical isomers [FL-no: 06.063]. No indication has been given that one of the possible isomers 
has preponderance in the commercial flavouring material (see Table 1). 
1.3. Natural Occurrence in Food 
Forty-three of the of the 59 substances in the present FGE have been reported to occur in the following 
food items: alcoholic beverages, cocoa, chinese quince peel, fruits and fruit juices (primarily apple and 
grape juice), tomatoes, potatoes, fish, meat, bread and butter. Quantitative data on the natural 
occurrence in food have been reported for 34 of these substances (TNO, 2000; TNO, 2011).  
Most of the substances occur in alcoholic beverages, e.g. rum: 
Table 1.3.1 Quantitative data for natural occurrence in food  
FL-no Name Found in 
06.041 1-Isobutoxy-1-ethoxy-2-methylpropane 0.1 mg/kg in rum 
06.042 1-Isobutoxy-1-ethoxy-3-methylbutane 5 mg/kg in rum 
06.044 1-Isobutoxy-1-ethoxypropane 0.25 mg/kg in rum 
06.045 1-Isobutoxy-1-isopentyloxy-2-methylpropane 0.8 mg/kg in rum 
06.046 1-Isobutoxy-1-isopentyloxy-3-methylbutane 0.25 mg/kg in rum 
06.047 1-Isopentyloxy-1-propoxyethane 2.5 mg/kg in rum 
06.050 1-Butoxy-1-ethoxyethane 0.5 mg/kg in rum 
06.052 1,1-Di-isobutoxy-2-methylpropane 0.5 mg/kg in rum 
06.053 1,1-Di-isobutoxyethane 1.5 mg/kg in rum, 1 mg/kg in cider 
06.054 1,1-Di-isobutoxypentane 0.05 mg/kg in rum 
06.055 1,1-Di-isopentyloxyethane 7.5 mg/kg in rum, 2 mg/kg in cider, 0.04 in cognac 
06.057 1,1-Diethoxy-2-methylbutane 2.5 mg/kg in rum 
06.058 1,1-Diethoxy-2-methylpropane 6 mg/kg in rum, 1.7 mg/kg in cognac 
06.059 1,1-Diethoxy-3-methylbutane 13 mg/kg in rum, 0.2 mg/kg in cognac 
06.061 1,1-Diethoxybutane 0.1 mg/kg in rum 
06.064 Diethoxymethane 0.8 mg/kg in rum 
06.065 1,1-Diethoxynonane 10 mg/kg in rum, 0.05 mg/kg in cider, 0.01 mg/kg 
in cognac 
06.067 1,1-Diethoxypentane 0.03 mg/kg in weinbrand, 0.004 mg/kg in cranberry 
06.069 1,1-Diethoxypropane 1.2 mg/kg in rum 
06.071 1,1-Dihexyloxyethane 0.01 mg/kg in cider 
06.079 1-Ethoxy-1-(2-methylbutoxy)ethane 2.5 mg/kg in rum 
06.083 1-Ethoxy-1-isopentyloxyethane 10 mg/kg in rum, 0.05 mg/kg in cider, 0.008-0.01 
mg/kg in grape brandy, up to 0.17 mg/kg in wine 
06.084 1-Ethoxy-1-methoxyethane 0.3 mg/kg in rum 
06.085 1-Ethoxy-1-pentyloxyethane 0.5 mg/kg in rum 
06.086 1-Ethoxy-1-propoxyethane 1.2 mg/kg in rum 
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Table 1.3.1 Quantitative data for natural occurrence in food  
FL-no Name Found in 
06.091 1-Isobutoxy-1-ethoxyethane 1.5 mg/kg in rum 
06.092 1-Isobutoxy-1-isopentyloxyethane 5 mg/kg in rum, 0.05 mg/kg in cider 
06.105 3-Methyl-1,1-di-isopentyloxybutane 0.1 mg/kg in rum 
06.106 2-Methyl-1,1-di-isopentyloxypropane 0.1 mg/kg in rum 
06.107 1-(2-Methylbutoxy)-1-isopentyloxyethane 2.3 mg/kg in rum 
06.123 1-Butoxy-1-isopentyloxyethane 0.5 mg/kg in rum 
06.124 1,1-Di-isobutoxy-3-methylbutane 0.8 mg/kg in rum 
06.129 1-Ethoxy-2-methyl-1-isopentyloxypropane 5 mg/kg in rum 
06.131 1-Ethoxy-1-(3-methylbutoxy)-3-methylbutane 4 mg/kg in rum 
 
Sixteen of the candidate substances have not been reported to occur naturally in any food items 
according to TNO (TNO, 2000) (see Table 1.3.2). Triethoxymethane [FL-no: 06.096] has been 
reported in amounts below the quantitation limits in butteroil examined after 6 – 8½ months of storage 
at – 18° C (Siek and Lindsay, 1968). The Panel concluded that these findings do not fulfil the Cramer 
class criteria of natural occurrence in food (Cramer et al., 1978). 
Table 1.3.2 Candidate substances not reported to occur naturally  
FL-no Name 
06.043 1-Isoamyloxy-1-ethoxypropane 
06.048 1-Isopentyloxy-1-propoxypropane 
06.051 1,1-Di-(2-methylbutoxy)ethane 
06.062 1,1-Diethoxydodecane 
06.063 1,1-Diethoxyhex-3-ene  
06.075 1,1-Dimethoxypentane 
06.076 1,1-Dimethoxypropane 
06.100 1,1-Dipentyloxyethane 
06.109 1,1-Diethoxy-3,7-dimethyloct-6-ene 
06.111 1-Ethoxy-1-methoxypropane 
06.114 1-Hexyloxy-1-isopentyloxyethane 
06.115 1-Isopentyloxy-1-pentyloxyethane 
06.125 1,1-Di-isobutoxypropane 
06.127 1-Ethoxy-1-isopentyloxypropane 
06.128 1-Ethoxy-1-pentyloxybutane 
06.130 1-Ethoxy-2-methyl-1-propoxypropane 
 
2. Specifications 
Purity criteria for the 59 substances have been provided by the Flavour Industry (EFFA, 2001b; 
EFFA, 2002a; EFFA, 2003s; Flavour Industry, 2007a; Flavour Industry, 2011c) (Table 1). 
Judged against the requirements in Annex II of Commission Regulation (EC) No 1565/2000 (EC, 
2000a), the specifications for 17 of the candidate substances, ([FL-no: 03.023, 06.041, 06.042, 06.043, 
06.045, 06.046, 06.047, 06.063, 06.105, 06.106, 06.107, 06.109, 06.115, 06.123, 06.124, 06.128 and 
06.129]), are insufficient, as identity tests are lacking and for one of the substances [FL-no: 06.063] 
has the stereoisomeric composition to be specified. The specifications are adequate for the other 42 
candidate substances (see Section 1.2 and Table1). 
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3. Intake Data 
Annual production volumes of the flavouring substances as surveyed by the Industry can be used to 
calculate the “Maximised Survey-derived Daily Intake” (MSDI) by assuming that the production 
figure only represents 60 % of the use in food due to underreporting and that 10 % of the total EU 
population are consumers (SCF, 1999a). 
However, the Panel noted that due to year-to-year variability in production volumes, to uncertainties 
in the underreporting correction factor and to uncertainties in the percentage of consumers, the 
reliability of intake estimates on the basis of the MSDI approach is difficult to assess. 
The Panel also noted that in contrast to the generally low per capita intake figures estimated on the 
basis of this MSDI approach, in some cases the regular consumption of products flavoured at use 
levels reported by the Flavour Industry in the submissions would result in much higher intakes. In 
such cases, the human exposure thresholds below which exposures are not considered to present a 
safety concern might be exceeded. 
Considering that the MSDI model may underestimate the intake of flavouring substances by certain 
groups of consumers, the SCF recommended also taking into account the results of other intake 
assessments (SCF, 1999a). 
One of the alternatives is the “Theoretical Added Maximum Daily Intake” (TAMDI) approach, which 
is calculated on the basis of standard portions and upper use levels (SCF, 1995) for flavourable 
beverages and foods in general, with exceptional levels for particular foods. This method is regarded 
as a conservative estimate of the actual intake by most consumers because it is based on the 
assumption that the consumer regularly eats and drinks several food products containing the same 
flavouring substance at the upper use level. 
One option to modify the TAMDI approach is to base the calculation on normal rather than upper use 
levels of the flavouring substances. This modified approach is less conservative (e.g., it may 
underestimate the intake of consumers being loyal to products flavoured at the maximum use levels 
reported) (EC, 2000a). However, it is considered as a suitable tool to screen and prioritise the 
flavouring substances according to the need for refined intake data (EFSA, 2004a). 
3.1. Estimated Daily per Capita Intake (MSDI Approach) 
The intake estimation is based on the Maximised Survey-derived Daily Intake (MSDI) approach, 
which involves the acquisition of data on the amounts used in food as flavourings (SCF, 1999a). These 
data are derived from surveys on annual production volumes in Europe. These surveys were conducted 
in 1995 by the International Organization of the Flavour Industry, in which flavour manufacturers 
reported the total amount of each flavouring substance incorporated into food sold in the EU during 
the previous year (IOFI, 1995). The intake approach does not consider the possible natural occurrence 
in food. 
Average per capita intake (MSDI) is estimated on the assumption that the amount added to food is 
consumed by 10 % of the population5 (Eurostat, 1998). This is derived for candidate substances from 
estimates of annual volume of production provided by Industry and incorporates a correction factor of 
0.6 to allow for incomplete reporting (60 %) in the Industry surveys (SCF, 1999a). 
The total annual volume of production of the 59 candidate substances in the present Flavouring Group 
Evaluation (FGE.03Rev2) from use as flavouring substances in Europe has been reported to be 
                                                     
 
5 EU figure 375 millions. This figure relates to EU population at the time for which production data are available, and is 
consistent (comparable) with evaluations conducted prior to the enlargement of the EU. No production data are available for 
the enlarged EU. 
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approximately 310 kg (EFFA, 2001d; EFFA, 2002a; EFFA, 2003s; Flavour Industry, 2007a; Flavour 
Industry, 2011c). Only two of the 59 substances have reported annual volumes over 10 kg (1,1-di-
isopentyloxyethane [FL-no: 06.055]: 111 kg/year and acetaldehyde ethyl isopropyl acetal [FL-no: 
06.137]: 100 kg/year). Four of the substances have annual production volumes over 6 kg and the 
estimated daily per capita intakes on the basis of the reported annual volume are 0.85 microgram for 
1,1-dipentyloxyethane [FL-no: 06.100], 1.2 microgram for 1-ethoxy-1-isopentyloxyethane [FL-no: 
06.083], 14 microgram for 1,1-di-isopentyloxyethane [FL-no: 06.055] and 0.77 microgram for 1,1-
diethoxypropane [FL-no: 06.069] (Table 2a).  
The orthoester [FL-no: 06.096] triethoxymethane has a reported annual production volume of 0.11 kg 
and the daily per capita intake based on this figure is 0.013 microgram (Table 2a). 
3.2. Intake Estimated on the Basis of the Modified TAMDI (mTAMDI) 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values 
is based on the approach used by SCF up to 1995 (SCF, 1995). 
The assumption is that a person may consume a certain amount of flavourable foods and beverages per 
day. 
For the 59 candidate substances information on food categories and normal and maximum use 
levels6,7,8 were submitted by the Flavour Industry (EFFA, 2001c; EFFA, 2001d; EFFA, 2002a; EFFA, 
2002i; EFFA, 2003s; EFFA, 2007a; Flavour Industry, 2007a; Flavour Industry, 2011c). The 59 
candidate substances are used in flavoured food products divided into the food categories, outlined in 
Annex III of the Commission Regulation (EC) No 1565/2000 (EC, 2000a), as shown in Table 3.1. For 
the present calculation of mTAMDI, the reported normal use levels were used. In the case where 
different use levels were reported for different food categories the highest reported normal use level 
was used. 
Table 3.1 Use of Candidate Substances. Use levels have been provided for all 59 candidate substances 
Food category Description Flavourings used 
01.0 Dairy products, excluding products of category 2 All except [FL-no: 
06.076, 06.137] 
02.0 Fats and oils, and fat emulsions (type water-in-oil) All except [FL-no: 
03.023, 06.137] 
03.0 Edible ices, including sherbet and sorbet All 
04.1 Processed fruits All except [FL-no: 
03.023, 06.137] 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and 
nuts & seeds 
None 
05.0 Confectionery All except [FL-no: 
06.137] 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, 
excluding bakery 
All except [FL-no:  
03.023, 06.049, 06.066, 
06.137] 
07.0 Bakery wares All except [FL-no: 
03.023, 06.137] 
08.0 Meat and meat products, including poultry and game All except [FL-no: 
03.023, 06.137] 
                                                     
 
6 ”Normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th percentile of reported 
usages (EFFA, 2002i). 
7 The normal and maximum use levels in different food categories (EC, 2000) have been extrapolated from figures derived 
from 12 model flavouring substances (EFFA, 2004e). 
8 The use levels from food category 5 “Confectionery” have been inserted as default values for food category 14.2 
“Alcoholic beverages” for substances for which no data have been given for food category 14.2 (EFFA, 2007a). 
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09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  All except [FL-no: 
03.023, 06.127, 06.137] 
10.0 Eggs and egg products None 
11.0 Sweeteners, including honey Only [FL-no: 06.096] 
12.0 Salts, spices, soups, sauces, salads, protein products etc. All except [FL-no: 
06.096, 06.137] 
13.0 Foodstuffs intended for particular nutritional uses All except [FL-no: 
03.023, 06.137] 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products All except [FL-no: 
03.023] 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts All 
15.0 Ready-to-eat savouries All except [FL-no: 
06.106, 06.137] 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in 
categories 1 – 15 
All except [FL-no: 
06.137] 
 
According to the Flavour Industry the normal use levels for the candidate substances are in the range 
of 0.003 - 20 mg/kg food, and the maximum use levels are in the range of 0.005 to 150 mg/kg (EFFA, 
2001c; EFFA, 2001d; EFFA, 2002a; EFFA, 2002i; EFFA, 2003s; EFFA, 2007a; Flavour Industry, 
2007a; Flavour Industry, 2011c) (see Table II.1.2, Annex II). 
The mTAMDI values for the 58 candidate substances from structural class I (see Section 5) range 
from 3 to 9500 microgram/person/day. For the one candidate substance from structural class III [FL-
no: 06.096] the mTAMDI is 1600 microgram/person/day. 
For detailed information on use levels and intake estimations based on the mTAMDI approach, see 
Section 6 and Annex II. 
4. Absorption, Distribution, Metabolism and Elimination 
It is anticipated that the acetals, the ester of the hemiacetal and the orthoester in the present Flavouring 
Group Evaluation (FGE.03Rev2) will undergo hydrolysis under acidic condition. The hydrolysis 
products are all relatively simple alcohols and aldehydes, and carboxylic acid which may be assumed 
to be rapidly absorbed and metabolised to innocuous products as discussed in more detail in Annex III, 
including references.  
However, there are few data available concerning hydrolysis of acetals in biological systems. From the 
available data on in vitro studies it can be concluded that simple acetals from linear or branched-chain 
alcohols and aldehydes may be hydrolysed in an acid environment such as artificial gastric juice (pH 
1.2), presumed to reflect the environment in the stomach, but hardly in a basic environment such as 
artificial intestinal fluid (pH 7.5), reflecting the situation in the gut. There is little information as to 
rates of hydrolysis.  
Enzymatic cleavage of acetals and further metabolism has been observed in vitro as well as in vivo. A 
few studies demonstrate that acetals may be hydrolysed enzymatically in liver microsomal 
preparations. Studies on conversion rate of the cyclic acetal paraldehyde to acetaldehyde also show 
that liver may contribute to enzymatical hydrolysis after oral intake or i.p. injection, and that 
hydrolysis may also take place in other tissues. 
There is very little information available on hydrolysis of the candidate acetals in the present 
flavouring group (FGE.03Rev2). From available data on supporting substances as well as on acetals 
with differing chemical structures it is clear that the rates of both acid hydrolysis and enzymatic 
hydrolysis will vary with different chemical structure of the acetals, and that hydrolysis sometimes 
may be slow and incomplete. Data submitted show that the rate of hydrolysis may vary considerably, 
even within groups of closely related substances with simple structures. The rate of hydrolysis may 
also depend on the solubility of the substance in aqueous media. There is currently not enough 
information to draw general conclusions on hydrolysis rates of acetals.  
Flavouring Group Evaluation 3, Revision 2
 
 
12 EFSA Journal 2011; 9(10):2312 
Nevertheless, hydrolysis data on compounds with structural similarity to the candidate substances 
show that the candidate acetals may be predicted to be hydrolysed, but it cannot be excluded that some 
amounts of the parent acetals may reach the systemic circulation. However, experimental studies 
indicate that acetals may also be hydrolysed enzymatically in the liver and probably also in other 
tissues. 
It is expected that the orthoester will be hydrolysed to innocuous compounds prior to absorption and 
that possible small amounts of the parent compound absorbed would be hydrolysed in the tissues. 
For more detailed information, see Annex III. 
5. Application of the Procedure for the Safety Evaluation of Flavouring Substances 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
Where the mTAMDI approach indicates that the intake of a flavouring substance might exceed its 
corresponding threshold of concern, a formal safety assessment is not carried out using the Procedure. 
In these cases the Panel requires more precise data on use and use levels. For comparison of the intake 
estimations based on the MSDI approach and the mTAMDI approach, see Section 6. 
For the safety evaluation of the 59 candidate substances from chemical groups 1, 2 and 4, the 
Procedure as outlined in Annex I was applied, based on the MSDI approach. The stepwise evaluations 
of the substances are summarised in Table 2a. 
Step 1 
All but one of the 59 substances are classified according to the decision tree approach presented by 
Cramer et al. (Cramer et al., 1978) into structural class I suggesting a low order of oral toxicity.  
One substance is triethoxymethane [FL-no: 06.096], an orthoester of formic acid, and is classified into 
structural class III, which means that it has a chemical structure that permits no strong initial 
presumption of safety.  
Step 2 
All candidate substances are expected to be metabolised into innocuous products at their estimated 
levels of intake based on the MSDI approach, and accordingly pass through the A-side of the 
Procedure for Safety Evaluation. 
Step A3 
The 58 candidate acetals from chemical groups 1, 2 and 4, which have all been assigned to class I, 
have estimated European daily per capita intakes from 0.001 to 14 microgram, which are below the 
threshold of concern of 1800 microgram/person/day for structural class I.  
The European daily per capita intake of the orthoester [FL-no: 06.096], assigned to structural class III, 
is 0.013 microgram, which is below the threshold of concern for structural class III compounds of 90 
microgram/person/day.  
The response for the 59 candidate substances to step A3 (of the Procedure, Appendix I) is “No” and 
the substances are accordingly not expected to be of safety concern at the levels of intakes based on 
the MSDI approach. 
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6. Comparison of the Intake Estimations Based on the MSDI Approach and the mTAMDI 
Approach 
The estimated intakes for the 58 candidate substances in structural class I based on the mTAMDI 
range from 3 to 9500 microgram/person/day. For 16 of the substances [FL-no: 06.041, 06.042, 06.043, 
06.045, 06.046, 06.047, 06.063, 06.105, 06.106, 06.107, 06.109, 06.115, 06.123, 06.124, 06.129 and 
06.137] the mTAMDI is above the threshold of concern of 1800 microgram/person/day  
The estimated intake of the orthoester [FL-no: 06.096], assigned to structural class III, based on the 
mTAMDI, is 1600 microgram/person/day, which is above the threshold of concern for structural class 
III substances of 90 microgram/person/day.  
Thus, for 17 of the substances further information is required. This would include more reliable intake 
data and then where required additional toxicity data. 
For comparison of the MSDI and mTAMDI values, see Table 6.1 
 
Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
03.023 1-Ethoxyethyl acetate 7.1 2.6 Class I 1800 
06.041 1-Isobutoxy-1-ethoxy-2-methylpropane 0.012 3900 Class I 1800 
06.042 1-Isobutoxy-1-ethoxy-3-methylbutane 0.012 3900 Class I 1800 
06.043 1-Isoamyloxy-1-ethoxypropane 0.012 3900 Class I 1800 
06.044 1-Isobutoxy-1-ethoxypropane 0.012 1600 Class I 1800 
06.045 1-Isobutoxy-1-isopentyloxy-2-methylpropane 0.012 3900 Class I 1800 
06.046 1-Isobutoxy-1-isopentyloxy-3-methylbutane 0.012 3900 Class I 1800 
06.047 1-Isopentyloxy-1-propoxyethane 0.037 3900 Class I 1800 
06.048 1-Isopentyloxy-1-propoxypropane 0.012 1600 Class I 1800 
06.049 1-Butoxy-1-(2-methylbutoxy)ethane 0.0061 1600 Class I 1800 
06.050 1-Butoxy-1-ethoxyethane 0.012 1300 Class I 1800 
06.051 1,1-Di-(2-methylbutoxy)ethane 0.012 1600 Class I 1800 
06.052 1,1-Di-isobutoxy-2-methylpropane 0.39 1600 Class I 1800 
06.053 1,1-Di-isobutoxyethane 0.13 1600 Class I 1800 
06.054 1,1-Di-isobutoxypentane 0.12 1600 Class I 1800 
06.055 1,1-Di-isopentyloxyethane 14 1600 Class I 1800 
06.057 1,1-Diethoxy-2-methylbutane 0.73 1600 Class I 1800 
06.058 1,1-Diethoxy-2-methylpropane 0.67 1600 Class I 1800 
06.059 1,1-Diethoxy-3-methylbutane 0.51 1600 Class I 1800 
06.061 1,1-Diethoxybutane 0.69 1600 Class I 1800 
06.062 1,1-Diethoxydodecane 0.37 1700 Class I 1800 
06.063 1,1-Diethoxyhex-3-ene 0.097 3900 Class I 1800 
06.064 Diethoxymethane 0.097 1600 Class I 1800 
06.065 1,1-Diethoxynonane 0.52 1600 Class I 1800 
06.066 1,1-Diethoxyoctane 0.0012 1600 Class I 1800 
06.067 1,1-Diethoxypentane 0.12 1600 Class I 1800 
06.069 1,1-Diethoxypropane 0.77 1600 Class I 1800 
06.070 1,1-Diethoxyundecane 0.0012 1600 Class I 1800 
06.071 1,1-Dihexyloxyethane 0.67 1600 Class I 1800 
06.073 1,1-Dimethoxyhexane 0.56 1600 Class I 1800 
06.074 Dimethoxymethane 0.012 1600 Class I 1800 
06.075 1,1-Dimethoxypentane 0.73 1600 Class I 1800 
06.076 1,1-Dimethoxypropane 0.12 1600 Class I 1800 
06.079 1-Ethoxy-1-(2-methylbutoxy)ethane 0.073 1600 Class I 1800 
06.082 1-Ethoxy-1-hexyloxyethane 0.37 1600 Class I 1800 
06.083 1-Ethoxy-1-isopentyloxyethane 1.2 1600 Class I 1800 
06.084 1-Ethoxy-1-methoxyethane 0.12 1600 Class I 1800 
06.085 1-Ethoxy-1-pentyloxyethane 0.012 1600 Class I 1800 
06.086 1-Ethoxy-1-propoxyethane 0.012 1600 Class I 1800 
06.091 1-Isobutoxy-1-ethoxyethane 0.097 1600 Class I 1800 
06.092 1-Isobutoxy-1-isopentyloxyethane 0.37 1600 Class I 1800 
06.100 1,1-Dipentyloxyethane 0.85 1600 Class I 1800 
06.105 3-Methyl-1,1-di-isopentyloxybutane 0.012 3900 Class I 1800 
06.106 2-Methyl-1,1-di-isopentyloxypropane 0.26 4900 Class I 1800 
06.107 1-(2-Methylbutoxy)-1-isopentyloxyethane 0.024 3900 Class I 1800 
06.109 1,1-Diethoxy-3,7-dimethyloct-6-ene 0.24 3900 Class I 1800 
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Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
06.111 1-Ethoxy-1-methoxypropane 0.012 1600 Class I 1800 
06.114 1-Hexyloxy-1-isopentyloxyethane 0.061 1600 Class I 1800 
06.115 1-Isopentyloxy-1-pentyloxyethane 0.24 3900 Class I 1800 
06.123 1-Butoxy-1-isopentyloxyethane 0.0061 3900 Class I 1800 
06.124 1,1-Di-isobutoxy-3-methylbutane 0.037 3900 Class I 1800 
06.125 1,1-Di-isobutoxypropane 0.37 1600 Class I 1800 
06.127 1-Ethoxy-1-isopentyloxypropane 0.012 1600 Class I 1800 
06.128 1-Ethoxy-1-pentyloxybutane 0.012 1600 Class I 1800 
06.129 1-Ethoxy-2-methyl-1-isopentyloxypropane 0.012 3900 Class I 1800 
06.130 1-Ethoxy-2-methyl-1-propoxypropane 0.012 1600 Class I 1800 
06.131 1-Ethoxy-1-(3-methylbutoxy)-3-methylbutane 0.012 1600 Class I 1800 
06.137 Acetaldehyde ethyl isopropyl acetal 12 9500 Class I 1800 
06.096 Triethoxymethane 0.013 1600 Class III 90 
7. Considerations of Combined Intakes from Use as Flavouring Substances 
Because of structural similarities of candidate and supporting substances, it can be anticipated that 
many of the flavourings are metabolised through the same metabolic pathways and that the 
metabolites may affect the same target organs. Further, in case of combined exposure to structurally 
related flavourings, the pathways could be overloaded. Therefore, combined intake should be 
considered. As flavourings not included in this FGE may also be metabolised through the same 
pathways, the combined intake estimates presented here are only preliminary. Currently, the combined 
intake estimates are only based on MSDI exposure estimates, although it is recognised that this may 
lead to underestimation of exposure. After completion of all FGEs, this issue should be readdressed. 
The total estimated combined daily per capita intake of structurally related flavourings is estimated by 
summing the MSDI for individual substances. 
On the basis of the reported annual production volumes in Europe (EFFA, 2001d; EFFA, 2002a; 
EFFA, 2003s; Flavour Industry, 2007a; Flavour Industry, 2011c), the estimated combined daily per 
capita intake of the 58 flavouring substances assigned to structural class I is 45 microgram, which 
does not exceed the threshold of concern for the structural class of 1800 microgram/person/day. 
The 58 candidate substances are structurally related to 12 supporting substances of which ten have 
been evaluated by the JECFA at its 57th session (JECFA, 2002b) and classified into structural class I, 
and two have been evaluated by CoE, 1992. It was noted that the estimated combined intake (in 
Europe) is approximately 270 microgram/capita/day for 11 of the 12 substances belonging to 
structural class I. The estimated level of intake in Europe was not reported for one of the supporting 
substances [FL-no: 06.081]. The total estimated combined intake of the 58 candidate and 11 
supporting substances (in Europe) based on the intake calculation by the MSDI approach is 315 
microgram/capita/day, which is below the threshold of concern for structural class I of 1800 
microgram/person/day. 
8. Toxicity 
8.1. Acute Toxicity 
Data are available for four candidate substances and for two supporting substances. The acute toxicity 
data are summarised in Annex IV, Table IV.1. 
8.2. Subacute, Subchronic, Chronic and Carcinogenicity Studies 
No studies were available on the candidate substances or on the supporting substances. 
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8.3. Developmental / Reproductive Toxicity Studies 
No studies were available on the candidate substances or on the supporting substances. 
8.4. Genotoxicity Studies 
Genotoxicity has been tested in vitro for three out of the 59 candidate substances. These are two 
acetals (dimethoxymethane [FL-no: 06.074] and diethoxymethane [FL-no: 06.064]) and one orthoester 
of formic acid (triethoxymethane [FL-no: 06.096]). One of the acetals [FL-no: 06.074] has been tested 
in vivo. Genotoxicity data are also available for some alcohols and aldehydes resulting from hydrolysis 
of acetals. The genotoxicity data are summarised in Annex IV, Table IV.4 and Table IV.5. 
Conclusion on genotoxicity: 
Dimethoxymethane [FL-no: 06.074] induced gene mutations in a bacterial reversion assay (Ames test) 
without metabolic activation but not in mammalian (CHO) cells at the HPRT locus in the presence and 
absence of metabolic activation. It was negative in a mouse bone marrow micronucleus assay. The 
studies on diethoxymethane [FL-no: 06.064] and triethoxymethane [FL-no: 06.096] were not 
adequately reported and the results obtained cannot be assessed. Additionally, there are some positive 
findings with potential hydrolysis products of acetals in vitro and in vivo, such as formaldehyde, 
methanol, ethanol and acetaldehyde. The genotoxicity of these compounds is well known. However, 
ethanol (and acetaldehyde) are endogenously synthesised and the daily in vivo formation of ethanol 
has been estimated to be 40 - 80 mg/kg body weight/day (JECFA, 1997a). Also, methanol and 
formaldehyde occur in mg amount in a number of foods (TNO, 2000; EFSA, 2006i) and are also 
endogenous metabolites. It has for instance been estimated that one cup of coffee containing 50 - 150 
mg caffeine may give rise to the formation of about 3 - 7.5 mg formaldehyde in the liver (Rubach, 
1987). 
It is concluded that the available data on genotoxicity do not give rise to safety concern with respect to 
genotoxicity for the candidate flavouring substances of FGE.03Rev2 at the estimated level of intake 
based on MSDI. 
Genotoxicity data are summarised in Annex IV, Table IV.4 and Table IV.5. 
9. Conclusions 
Of the 59 flavouring substances 57 are acetals of branched- and straight-chain aliphatic saturated 
primary alcohols and branched- and straight-chain saturated or unsaturated aldehydes, one is an 
orthoester of formic acid and one is an ester of a hemiacetal. The substances belong to chemical 
groups 1, 2 and 4.  
Thirty-three of the 59 substances possess a chiral centre. In most of these cases, the chirality results 
solely because the acetal is asymmetric, i.e. it is formed from an aldehyde and two different alcohols, 
none of which contains a chiral centre [FL-no: 03.023, 06.041, 06.042, 06.043, 06.044, 06.045, 
06.046, 06.047, 06.048, 06.050, 06.082, 06.083, 06.084, 06.085, 06.086, 06.091, 06.092, 06.111, 
06.114, 06.115, 06.123, 06.127, 06.128, 06.129, 06.130, 06.131 and 06.137]. According to the 
information provided by Industry since the publication of FGE.03Rev1,all these acetal derivatives 
occur as their mixtures of optical isomers (of the acetal moiety), i.e. as the racemates. This new 
information has implications for two of the substances in the present FGE, [FL-no: 06.043 and 
06.127], as the Industry has informed that both are racemic mixtures of isomers and they then turned 
out to be identical substances. For three substances either the aldehyde [FL-no: 06.057 and 06.109] or 
the alcohol moiety [FL-no: 06.051] contain one chiral centre. According to the information provided 
[FL-no: 06.051, 06.057 and 06.109] are used as a racemic mixture. Three of the substances [FL-no: 
06.049, 06.079 and 06.107] have one chiral centre in the aldehyde moiety and one in the alcohol 
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moiety. According to the information provided by Industry both the alcohol and the aldehyde moiety 
occur as their racemic mixtures (mixtures of R- and S-enantiomers).  
Due to the presence and the position of a double bond, one of the 59 substances can exist as 
geometrical isomers [FL-no: 06.063]. No indication has been given that one of the possible isomers 
has preponderance in the commercial flavouring material. 
Fifty-eight of the flavouring substances belong to structural class I and the orthoester [FL-no: 06.096] 
belongs to structural class III. 
Forty-three of the substances in the present group of 59 substances have been reported to occur 
naturally in a wide range of food items. 
According to the default MSDI approach, the 58 candidate substances assigned to structural class I 
have intakes in Europe from 0.001 to 14 microgram/capita/day, which are below the threshold of 
concern for structural class I of 1800 microgram/person/day. Likewise the estimated level of intake for 
the orthoester of 0.013 microgram/capita/day is below the threshold of concern for structural class III 
of 90 microgram/person/day.  
On the basis of the reported annual production volumes in Europe (MSDI approach) the combined 
intake of the 58 candidate substances is 45 microgram/person/day. The total combined intake of the 58 
candidate and 11 supporting substances for which intake data are available is 315 
microgram/person/day, which is below the threshold of concern for structural class I. 
Adequately reported genotoxicity studies are only available for one candidate substance [FL-no: 
06.074] and not for any of the supporting substances. These studies do not give rise to safety concern 
with respect to genotoxicity of this candidate flavouring substance. Consideration was given to 
methanol, formaldehyde, ethanol and acetaldehyde that are potential hydrolysis products of several of 
the acetals in the present Flavouring Group Evaluation. In the light of the endogenous formation in 
humans of considerably larger amounts of the compounds without harmful effects, humans are 
considered to sufficiently metabolise the compounds formed from hydrolysis of the acetals at the 
estimated per capita intakes, based on maximised annual production volumes. Their use as flavouring 
substances at such level of intake is therefore not considered to be of safety concern. 
The 59 candidate substances are expected to be metabolised to innocuous products. 
There are no toxicological studies available on the 59 candidate substances or the supporting 
substances other than some data on acute toxicity.  
It is considered that on the basis of the default MSDI approach, the 57 candidate acetals, the one 
candidate orthoester [FL-no: 06.096] and the ester of a hemiacetal [FL-no: 03.023] would not give rise 
to safety concerns at the estimated levels of intake arising from their use as flavouring substances.  
When the estimated intakes were based on the mTAMDI approach they ranged from 3 to 9500 
microgram/person/day for the 58 candidate substances from structural class I.  The intakes were above 
the threshold of concern for structural class I of 1800 microgram/person/day for 16 of the flavouring 
substances [FL-no: 06.041, 06.042, 06.043, 06.045, 06.046, 06.047, 06.063, 06.105, 06.106, 06.107, 
06.109, 06.115, 06.123, 06.124, 06.129 and 06.137]. For the one candidate substance from structural 
class III [FL-no: 06.096], the mTAMDI is 1600 microgram/person/day, which is above the threshold 
of concern for structural class III of 90 microgram/person/day. The 42 substances which have 
mTAMDI intake estimates below the threshold of concern for structural class I, are also expected to be 
metabolised to innocuous products. 
Thus, for 17 of the 59 flavouring substances considered in this Opinion, the intakes, estimated on the 
basis of the mTAMDI, exceed the relevant threshold for their structural class to which the flavouring 
substance has been assigned. Therefore, for these 17 substances more reliable exposure data are 
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required. On the basis of such additional data, these flavouring substances should be reconsidered 
using the Procedure. Subsequently, additional data might become necessary.  
In order to determine whether the conclusion for the 59 candidate substances can be applied to the 
materials of commerce, it is necessary to consider the available specifications. Adequate specifications 
including complete purity criteria and identity tests for the materials of commerce have been provided 
for 42 of the 59 flavouring candidate substances. The specifications are not adequate for 17 substances 
[FL-no: 03.023, 06.041, 06.042, 06.043, 06.045, 06.046, 06.047, 06.063, 06.105, 06.106, 06.107, 
06.109, 06.115, 06.123, 06.124, 06.128 and 06.129] as identity tests are lacking and for one of 
substances [FL-no: 06.063] has the stereoisomeric composition to be specified. Thus, the final 
evaluation of the materials of commerce cannot be performed for 17 substances ([FL-no: 03.023, 
06.041, 06.042, 06.043, 06.045, 06.046, 06.047, 06.063, 06.105, 06.106, 06.107, 06.109, 06.115, 
06.123, 06.124, 06.128, 06.129]), pending further information.  
For the remaining 42 substances [FL-no: 06.044, 06.048, 06.049, 06.050, 06.051, 06.052, 06.053, 
06.054, 06.055, 06.057, 06.058, 06.059, 06.061, 06.062, 06.064, 06.065, 06.066, 06.067, 06.069, 
06.070, 06.071, 06.073, 06.074, 06.075, 06.076, 06.079, 06.082, 06.083, 06.084, 06.085, 06.086, 
06.091, 06.092, 06.096, 06.100, 06.111, 06.114, 06.125, 06.127, 06.130, 06.131 and 06.137] the Panel 
concluded that they would present no safety concern at the estimated levels of intake based on the 
MSDI approach. 
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TABLE 1: SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FLAVOURING GROUP EVALUATION 3, REVISION 2 
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 3, Revision 2 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification 
comments 
03.023 
 
1-Ethoxyethyl acetate 
O O O  
4069 
 
1608-72-6 
Liquid 
C6H12O3 
132.16 
Very soluble 
Mostly soluble 
137.14 
n.a. 
 
95 % 
1.390-1.391 
0.946-0.956 
ID 7). 
Racemate  
(EFFA, 2010a). 
06.041 
 
1-Isobutoxy-1-ethoxy-2-
methylpropane 
O O
 
 
10055 
 
Liquid 
C10H22O2 
174.28 
Slightly soluble 
Freely soluble 
170 
 
 
95 % 
1.398-1.404 
0.824-0.830 
ID 7). 
Racemate  
(EFFA, 2010a). 
CASrn is missing. 
06.042 
 
1-Isobutoxy-1-ethoxy-3-
methylbutane 
O O
 
10057 
85136-40-9 
Liquid 
C11H24O2 
188.31 
Slightly soluble 
Freely soluble 
191 
 
 
95 % 
1.397-1.403 
0.838-0.844 
ID 7). 
Racemate  
(EFFA, 2010a). 
06.043 
 
1-Isoamyloxy-1-ethoxypropane OO
 
 
10038 
238757-30-7 
Liquid 
C10H22O2 
174.28 
Practically insoluble 
or insoluble 
Freely soluble 
183 
 
 
95 % 
1.398-1.404 
0.837-0.843 
ID 7). 
Racemate (2010a). 
This substance is 
identical to [FL-no: 
06.127]. 
06.044 
 
1-Isobutoxy-1-ethoxypropane 
O
O
 
 
10058 
67234-04-2 
Liquid 
C9H20O2 
160.26 
Insoluble 
Freely soluble 
162 
 
MS 
95 % 
1.395-1.401 
0.840-0.845 
 
Racemate  
(EFFA, 2010a). 
06.045 
 
1-Isobutoxy-1-isopentyloxy-2-
methylpropane 
O O
 
 
10061 
 
Liquid 
C13H28O2 
216.36 
Slightly soluble 
Freely soluble 
219 
 
 
95 % 
1.407-1.412 
0.828-0.834 
ID 7). 
Racemate  
(EFFA, 2010a). 
CASrn is missing. 
06.046 
 
1-Isobutoxy-1-isopentyloxy-3-
methylbutane 
O O
 
10060 
 
Liquid 
C14H30O2 
230.39 
Slightly soluble 
Freely soluble 
237 
 
 
95 % 
1.404-1.410 
0.836-0.842 
ID 7). 
Racemate  
(EFFA, 2010a). 
CASrn is missing. 
06.047 
 
1-Isopentyloxy-1-propoxyethane 
O O  
 
10065 
238757-63-6 
Liquid 
C10H22O2 
174.28 
Slightly soluble 
Freely soluble 
183 
 
 
95 % 
1.395-1.401 
0.836-0.842 
ID 7). 
Racemate  
EFFA, 2010a). 
Missing CASrn. 
06.048 
 
1-Isopentyloxy-1-propoxypropane 
O
O
 
 
10066 
238757-56-8 
Liquid 
C11H24O2 
188.31 
Insoluble 
Freely soluble 
203 
 
NMR 
95 % 
1.403-1.409 
0.840-0.845 
 
Racemate  
(EFFA, 2010a). 
CASrn in Register 
not valid. The 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 3, Revision 2 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification 
comments 
CASrn to be 
changed to 
238757-65-8. 
06.049 
 
1-Butoxy-1-(2-
methylbutoxy)ethane 
O
O
 
 
 
77249-20-8 
Liquid 
C11H24O2 
188.31 
Insoluble 
Freely soluble 
203 
 
NMR 
95 % 
1.401-1.407 
0.839-0.844 
 
Racemate: 
Alcohol moiety: 
racemic. Aldehyde 
moity: racemic 
(EFFA, 2010a) 
06.050 
 
1-Butoxy-1-ethoxyethane 
O
O
 
 
10003 
57006-87-8 
Liquid 
C8H18O2 
146.23 
Slightly soluble 
Freely soluble 
148 
 
MS 
95 % 
1.396-1.402 
0.826-0.832 
 
Racemate  
(EFFA, 2010a). 
06.051 
 
1,1-Di-(2-methylbutoxy)ethane 
O
O
 
 
 
13535-43-8 
Liquid 
C12H26O2 
202.34 
Insoluble 
Freely soluble 
205 
 
MS 
95 % 
1.413-1.419 
0.823-0.829 
 
Racemate. 
06.052 
 
1,1-Di-isobutoxy-2-methylpropane 
O
O
 
10025 
13262-24-3 
Liquid 
C12H26O2 
202.34 
Insoluble 
Freely soluble 
194 
 
MS 
95 % 
1.406-1.412 
0.823-0.829 
 
 
06.053 
 
1,1-Di-isobutoxyethane 
O
O
 
 
10023 
5669-09-0 
Liquid 
C10H22O2 
174.28 
Insoluble 
Freely soluble 
171 
 
MS 
95 % 
1.399-1.405 
0.817-0.823 
 
 
06.054 
 
1,1-Di-isobutoxypentane 
O
O  
10026 
13262-27-6 
Liquid 
C13H28O2 
216.36 
Insoluble 
Freely soluble 
230 
 
NMR 
95 % 
1.415-1.421 
0.838-0.843 
 
 
06.055 
1729 
1,1-Di-isopentyloxyethane 
O
O
 
10028 
13002-09-0 
Liquid 
C12H26O2 
202.34 
Insoluble 
Freely soluble 
210 
 
MS 
95 % 
1.411-1.417 
0.826-0.832 
 
 
06.057 
 
1,1-Diethoxy-2-methylbutane 
O
O
 
 
10013 
3658-94-4 
Liquid 
C9H20O2 
160.26 
Slightly soluble 
Freely soluble 
162 
 
MS 
95 % 
1.393-1.399 
0.837-0.842 
 
Racemate. 
06.058 
 
1,1-Diethoxy-2-methylpropane 
O
O
 
 
10015 
1741-41-9 
Liquid 
C8H18O2 
146.23 
Slightly soluble 
Freely soluble 
135 
 
MS 
95 % 
1.390-1.396 
0.826-0.832 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 3, Revision 2 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification 
comments 
06.059 
1730 
1,1-Diethoxy-3-methylbutane 
O
O
 
4371 
10014 
3842-03-3 
Liquid 
C9H20O2 
160.26 
Slightly soluble 
Freely soluble 
156 
 
MS 
95 % 
1.398-1.404 
0.832-0.838 
 
 
06.061 
 
1,1-Diethoxybutane 
O
O
 
 
10009 
3658-95-5 
Liquid 
C8H18O2 
146.23 
Slightly soluble 
Freely soluble 
143 
 
MS 
97 % 
1.393-1.399 
0.820-0.829 
 
 
06.062 
 
1,1-Diethoxydodecane 
O
O
 
 
 
53405-98-4 
Liquid 
C16H34O2 
258.44 
Insoluble 
Freely soluble 
300 
 
MS 
95 % 
1.429-1.435 
0.842-0.847 
 
 
06.063 
 
1,1-Diethoxyhex-3-ene   6) 
O
O
Z-form shown  
 
 
73545-18-3 
Liquid 
C10H20O2 
172.27 
Practically insoluble 
or insoluble 
Freely soluble 
65 (0.3 hPa) 
 
 
95 % 
1.408-1.414 
0.856-0.862 
ID 7). 
CASrn in Register 
refers to the (Z)-
isomer. 
06.064 
 
Diethoxymethane O O   
10012 
462-95-3 
Liquid 
C5H12O2 
104.15 
Soluble 
Freely soluble 
88 
 
MS 
95 % 
1.370-1.379 
0.827-0.833 
 
 
06.065 
 
1,1-Diethoxynonane 
O
O
 
 
10016 
54815-13-3 
Liquid 
C13H28O2 
216.36 
Insoluble 
Freely soluble 
106 (13 hPa) 
 
MS 
95 % 
1.419-1.425 
0.842-0.847 
 
 
06.066 
 
1,1-Diethoxyoctane 
O
O
 
 
 
54889-48-4 
Liquid 
C12H26O2 
202.34 
Insoluble 
Freely soluble 
222 
 
MS 
95 % 
1.414-1.420 
0.829-0.835 
 
 
06.067 
 
1,1-Diethoxypentane 
O
O
 
 
10017 
3658-79-5 
Liquid 
C9H20O2 
160.26 
Insoluble 
Freely soluble 
163 
 
MS 
95 % 
1.399-1.405 
0.826-0.832 
 
 
06.069 
 
1,1-Diethoxypropane 
O
O
 
 
10018 
4744-08-5 
Liquid 
C7H16O2 
132.20 
Slightly soluble 
Freely soluble 
123 
 
MS 
95 % 
1.386-1.392 
0.824-0.830 
 
 
06.070 
 
1,1-Diethoxyundecane 
O
O
 
 
 
53405-97-3 
Liquid 
C15H32O2 
244.42 
Insoluble 
Freely soluble 
285 
 
MS 
95 % 
1.426-1.432 
0.842-0.847 
 
 
06.071 
 
1,1-Dihexyloxyethane 
O
O
 
 
10022 
5405-58-3 
Liquid 
C14H30O2 
230.39 
Insoluble 
Freely soluble 
153 (32 hPa) 
 
MS 
95 % 
1.420-1.426 
0.833-0.839 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 3, Revision 2 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification 
comments 
06.073 
 
1,1-Dimethoxyhexane 
O
O
 
 
 
1599-47-9 
Liquid 
C8H18O2 
146.23 
Slightly soluble 
Freely soluble 
158 
 
MS 
95 % 
1.403-1.409 
0.843-0.849 
 
 
06.074 
 
Dimethoxymethane O O   
10031 
109-87-5 
Liquid 
C3H8O2 
76.10 
Soluble 
Freely soluble 
42 
0 
MS 
95 % 
1.350-1.356 
0.855-0.862 
 
 
06.075 
 
1,1-Dimethoxypentane 
O
O
 
 
 
26450-58-8 
Liquid 
C7H16O2 
132.20 
Slightly soluble 
Freely soluble 
131 
 
MS 
95 % 
1.394-1.400 
0.839-0.844 
 
 
06.076 
 
1,1-Dimethoxypropane 
O
O
 
 
 
4744-10-9 
Liquid 
C5H12O2 
104.15 
Slightly soluble 
Freely soluble 
88 
 
MS 
95 % 
1.376-1.382 
0.842-0.848 
 
 
06.079 
 
1-Ethoxy-1-(2-
methylbutoxy)ethane 
O
O
 
 
10040 
13602-09-0 
Liquid 
C9H20O2 
160.26 
Slightly soluble 
Freely soluble 
162 
 
NMR 
95 % 
1.392-1.398 
0.838-0.843 
Racemate: 
Alcohol moiety: 
racemic. Aldehyde 
moiety: racemic 
(EFFA, 2010a). 
06.082 
 
1-Ethoxy-1-hexyloxyethane 
O
O
 
 
11948 
54484-73-0 
Liquid 
C10H22O2 
174.28 
Slightly soluble 
Freely soluble 
66 (17 hPa) 
 
MS 
95 % 
1.408-1.414 
0.829-0.835 
 
Racemate  
(EFFA, 2010a). 
06.083 
 
1-Ethoxy-1-isopentyloxyethane 
O
O
 
 
10037 
13442-90-5 
Liquid 
C9H20O2 
160.26 
Insoluble 
Freely soluble 
166 
 
MS 
95 % 
1.401-1.407 
0.838-0.843 
 
Racemate  
(EFFA, 2010a). 
06.084 
 
1-Ethoxy-1-methoxyethane 
O
O
 
 
10039 
10471-14-4 
Liquid 
C5H12O2 
104.15 
Slightly soluble 
Freely soluble 
85 
 
MS 
95 % 
1.372-1.378 
0.825-0.831 
 
Racemate  
(EFFA, 2010a). 
06.085 
 
1-Ethoxy-1-pentyloxyethane 
O
O
 
 
10046 
59184-43-9 
Liquid 
C9H20O2 
160.26 
Insoluble 
Freely soluble 
175 
 
MS 
95 % 
1.404-1.410 
0.840-0.845 
 
Racemate  
(EFFA, 2010a). 
CASrn in Register 
to be changed to 
13442-89-2. 
06.086 
 
1-Ethoxy-1-propoxyethane 
O
O
 
 
10050 
20680-10-8 
Liquid 
C7H16O2 
132.20 
Slightly soluble 
Freely soluble 
126 
 
MS 
95 % 
1.389-1.395 
0.827-0.837 
 
Racemate  
(EFFA, 2010a). 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 3, Revision 2 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification 
comments 
06.091 
 
1-Isobutoxy-1-ethoxyethane 
O
O
 
 
10054 
6986-51-2 
Liquid 
C8H18O2 
146.23 
Slightly soluble 
Freely soluble 
155 
 
MS 
95 % 
1.381-1.387 
0.818-0.824 
 
Racemate  
(EFFA, 2010a). 
06.092 
 
1-Isobutoxy-1-isopentyloxyethane 
O
O
 
10059 
75048-15-6 
Liquid 
C11H24O2 
188.31 
Insoluble 
Freely soluble 
191 
 
NMR 
95 % 
1.406-1.412 
0.838-0.843 
 
Racemate  
(EFFA, 2010a). 
06.096 
 
Triethoxymethane 
O O
O
 
 
10903 
122-51-0 
Liquid 
C7H16O3 
148.20 
Slightly soluble 
Freely soluble 
144 
 
MS 
98 % 
1.389-1.395 
0.886-0.895 
 
 
06.100 
 
1,1-Dipentyloxyethane 
O
O
 
 
10032 
13002-08-9 
Liquid 
C12H26O2 
202.34 
Insoluble 
Freely soluble 
224 
 
NMR MS 
95 % 
1.414-1.420 
0.833-0.839 
 
 
06.105 
 
3-Methyl-1,1-di-
isopentyloxybutane 
OO
 
10070 
13285-51-3 
Liquid 
C15H32O2 
244.42 
Slightly soluble 
Freely soluble 
252 
 
 
95 % 
1.411-1.417 
0.846-0.852 
ID 7). 
 
06.106 
 
2-Methyl-1,1-di-
isopentyloxypropane 
OO
 
10071 
13112-63-5 
Liquid 
C14H30O2 
230.39 
Slightly soluble 
Freely soluble 
100 (11 hPa) 
 
 
95 % 
1.416-1.422 
0.835-0.841 
ID 7). 
 
06.107 
 
1-(2-Methylbutoxy)-1-
isopentyloxyethane OO
 
 
10068 
13548-84-0 
Liquid 
C12H26O2 
202.33 
Slightly soluble 
Freely soluble 
223 
 
 
95 % 
1.413-1.419 
0.824-0.830 
ID 7). 
Racemate:  
Alcohol moiety: 
racemic. Aldehyde 
moiety: racemic 
(EFFA, 2010a). 
06.109 
 
1,1-Diethoxy-3,7-dimethyloct-6-
ene 
O
O  
 
71662-17-4 
Liquid 
C14H28O2 
228.37 
Practically insoluble 
or insoluble 
Freely soluble 
232 
 
 
95 % 
1.411-1.417 
0.857-0.863 
ID 7). 
 Racemate  
(EFFA, 2010a). 
06.111 
 
1-Ethoxy-1-methoxypropane 
O
O
 
- 
- 
127248-84-4 
Liquid 
C6H14O2 
118.18 
Slightly soluble 
Freely soluble 
108 
 
MS 
95 % 
1.378-1.384 
0.838-0.843 
 
Racemate  
(EFFA, 2010a). 
06.114 
 
1-Hexyloxy-1-isopentyloxyethane 
O
O
 
 
233665-90-2 
Liquid 
C13H28O2 
216.36 
Insoluble 
Freely soluble 
241 
 
NMR 
95 % 
1.415-1.421 
0.837-0.842 
 
Racemate  
(EFFA, 2010a) 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 3, Revision 2 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification 
comments 
06.115 
 
1-Isopentyloxy-1-pentyloxyethane 
O O  
 
 
13442-92-7 
Liquid 
C12H26O2 
202.33 
Slightly soluble 
Freely soluble 
222 
 
 
95 % 
1.410-1.416 
0.827-0.833 
ID 7). 
Racemate  
(EFFA, 2010a). 
06.123 
 
1-Butoxy-1-isopentyloxyethane 
OO  
 
10004 
238757-27-2 
Liquid 
C11H24O2 
188.31 
Slightly soluble 
Freely soluble 
202 
 
 
95 % 
1.412-1.418 
0.837-0.843 
ID 7). 
Racemate  
(EFFA, 2010a). 
06.124 
 
1,1-Di-isobutoxy-3-methylbutane 
OO
 
10024 
13439-98-0 
Liquid 
C13H28O2 
216.36 
Slightly soluble 
Freely soluble 
219 
 
 
95 % 
1.416-1.422 
0.840-0.846 
ID 7). 
 
06.125 
 
1,1-Di-isobutoxypropane 
O
O
 
 
10027 
13002-11-4 
Liquid 
C11H24O2 
188.31 
Insoluble 
Freely soluble 
82 (26 hPa) 
 
MS 
95 % 
1.404-1.410 
0.838-0.843 
 
 
06.127 
 
1-Ethoxy-1-isopentyloxypropane 
O
O
 
 
10036 
238757-30-7 
Liquid 
C10H22O2 
174.28 
Insoluble 
Freely soluble 
183 
 
MS 
95 % 
1.403-1.409 
0.839-0.844 
 
Racemate  
(EFFA, 2010a). 
This substance is 
identical to [FL-no: 
06.043]. 
06.128 
 
1-Ethoxy-1-pentyloxybutane 
O
O
 
 
10045 
3658-92-2 
Liquid 
C11H24O2 
188.31 
Insoluble 
Freely soluble 
99 (33 hPa) 
 
 
95 % 
1.409-1.415 
0.836-0.842 
ID 7). 
Racemate  
(EFFA, 2010a) 
06.129 
 
1-Ethoxy-2-methyl-1-
isopentyloxypropane 
OO  
 
10043 
253679-74-2 
Liquid 
C11H24O2 
188.31 
Slightly soluble 
Freely soluble 
191 
 
 
95 % 
1.396-1.402 
0.825-0.831 
ID 7). 
Racemate  
(EFFA, 2010a). 
06.130 
 
1-Ethoxy-2-methyl-1-
propoxypropane 
O
O
 
 
10044 
238757-42-1 
Liquid 
C9H20O2 
160.26 
Insoluble 
Freely soluble 
162 
 
NMR 
95 % 
1.394-1.400 
0.838-0.843 
 
Racemate  
(EFFA, 2010a) 
06.131 
 
1-Ethoxy-1-(3-methylbutoxy)-3-
methylbutane 
O
O
 
 
10042 
 
Liquid 
C12H26O2 
202.34 
Insoluble 
Freely soluble 
211 
 
NMR 
95 % 
1.405-1.411 
0.839-0.844 
 
Racemate  
(EFFA, 2010a). 
CASrn is missing. 
06.137 
 
Acetaldehyde ethyl isopropyl 
acetal O
O  
4432 
 
25334-93-4 
Liquid 
C7H16O2 
132.20 
Slightly soluble 
Soluble 
126 
 
IR NMR MS 
90 % 
1.396 
0.840 
 
Racemate. 
90 % Acet-
aldehyde ethyl 
isopropyl acetal, 8 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 3, Revision 2 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification 
comments 
% Acetaldehyde 
diethylacetal and 
less than 0.5 % of 
each: isopropyl 
vinyl ether, ethyl 
acetate, isopropyl 
acetate and 
acetaldehyde 
(Flavour Industry, 
2011 c). 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
6) Stereoisomeric composition not specified. 
7) ID: Missing identification test. 
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TABLE 2A: SUMMARY OF SAFETY EVALUATION APPLYING THE PROCEDURE (BASED ON INTAKES CALCULATED BY THE MSDI APPROACH) 
Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation 
remarks 
03.023 
 
1-Ethoxyethyl acetate 
O O O
7.1 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.041 
 
1-Isobutoxy-1-ethoxy-2-methylpropane 
O O
0.012 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.042 
 
1-Isobutoxy-1-ethoxy-3-methylbutane 
O O
0.012 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.043 
 
1-Isoamyloxy-1-ethoxypropane OO 0.012 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.044 
 
1-Isobutoxy-1-ethoxypropane 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.045 
 
1-Isobutoxy-1-isopentyloxy-2-methylpropane 
O O
0.012 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.046 
 
1-Isobutoxy-1-isopentyloxy-3-methylbutane 
O O
0.012 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.047 
 
1-Isopentyloxy-1-propoxyethane 
O O
0.037 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.048 
 
1-Isopentyloxy-1-propoxypropane 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.049 
 
1-Butoxy-1-(2-methylbutoxy)ethane 
O
O 0.0061 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.050 
 
1-Butoxy-1-ethoxyethane 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation 
remarks 
06.051 
 
1,1-Di-(2-methylbutoxy)ethane 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.052 
 
1,1-Di-isobutoxy-2-methylpropane 
O
O
0.39 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.053 
 
1,1-Di-isobutoxyethane 
O
O 0.13 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.054 
 
1,1-Di-isobutoxypentane 
O
O 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.055 
1729 
1,1-Di-isopentyloxyethane 
O
O
14 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.057 
 
1,1-Diethoxy-2-methylbutane 
O
O 0.73 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.058 
 
1,1-Diethoxy-2-methylpropane 
O
O 0.67 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.059 
1730 
1,1-Diethoxy-3-methylbutane 
O
O 0.51 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.061 
 
1,1-Diethoxybutane 
O
O 0.69 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.062 
 
1,1-Diethoxydodecane 
O
O 0.37 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.063 
 
1,1-Diethoxyhex-3-ene 
O
O
Z-form shown
0.097 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.064 
 
Diethoxymethane O O  0.097 
 
Class I 
A3: Intake below threshold 
4) 6)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation 
remarks 
06.065 
 
1,1-Diethoxynonane 
O
O 0.52 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.066 
 
1,1-Diethoxyoctane 
O
O 0.0012 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.067 
 
1,1-Diethoxypentane 
O
O 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.069 
 
1,1-Diethoxypropane 
O
O 0.77 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.070 
 
1,1-Diethoxyundecane 
O
O 0.0012 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.071 
 
1,1-Dihexyloxyethane 
O
O 0.67 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.073 
 
1,1-Dimethoxyhexane 
O
O 0.56 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.074 
 
Dimethoxymethane O O  0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.075 
 
1,1-Dimethoxypentane 
O
O 0.73 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.076 
 
1,1-Dimethoxypropane 
O
O 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.079 
 
1-Ethoxy-1-(2-methylbutoxy)ethane 
O
O 0.073 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.082 
 
1-Ethoxy-1-hexyloxyethane 
O
O 0.37 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.083 
 
1-Ethoxy-1-isopentyloxyethane 
O
O 1.2 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.084 
 
1-Ethoxy-1-methoxyethane 
O
O 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.085 
 
1-Ethoxy-1-pentyloxyethane 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation 
remarks 
06.086 
 
1-Ethoxy-1-propoxyethane 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.091 
 
1-Isobutoxy-1-ethoxyethane 
O
O 0.097 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.092 
 
1-Isobutoxy-1-isopentyloxyethane 
O
O
0.37 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.100 
 
1,1-Dipentyloxyethane 
O
O 0.85 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.105 
 
3-Methyl-1,1-di-isopentyloxybutane 
OO
0.012 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.106 
 
2-Methyl-1,1-di-isopentyloxypropane 
OO
0.26 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.107 
 
1-(2-Methylbutoxy)-1-isopentyloxyethane 
OO
0.024 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.109 
 
1,1-Diethoxy-3,7-dimethyloct-6-ene 
O
O 0.24 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.111 
 
1-Ethoxy-1-methoxypropane 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.114 
 
1-Hexyloxy-1-isopentyloxyethane 
O
O
0.0 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.115 
 
1-Isopentyloxy-1-pentyloxyethane 
O O
0.24 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.123 
 
1-Butoxy-1-isopentyloxyethane 
OO
0.0061 
 
Class I 
A3: Intake below threshold 
4) 7)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation 
remarks 
06.124 
 
1,1-Di-isobutoxy-3-methylbutane 
OO
0.037 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.125 
 
1,1-Di-isobutoxypropane 
O
O 0.37 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.127 
 
1-Ethoxy-1-isopentyloxypropane 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.128 
 
1-Ethoxy-1-pentyloxybutane 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.129 
 
1-Ethoxy-2-methyl-1-isopentyloxypropane 
OO
0.012 
 
Class I 
A3: Intake below threshold 
4) 7)  
06.130 
 
1-Ethoxy-2-methyl-1-propoxypropane 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.131 
 
1-Ethoxy-1-(3-methylbutoxy)-3-methylbutane 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.137 
 
Acetaldehyde ethyl isopropyl acetal 
O
O
12 
 
Class I 
A3: Intake below threshold 
4) 6)  
06.096 
 
Triethoxymethane 
O O
O 0.013 
 
Class III 
A3: Intake below threshold 
4) 6)  
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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TABLE 2B: EVALUATION STATUS OF HYDROLYSIS PRODUCTS OF CANDIDATE ESTERS  
Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
 Formaldehyde 
CH2O 
30.03 
O
H
H
 
Not evaluated as flavouring substance  Not in EU-Register. 
 Methanol 
CH3O 
31.03 
H
H
H
OH
Not evaluated as flavouring substance  Not in EU-Register. 
02.001 2-Methylpropan-1-ol 
251 
OH
 
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
02.002 Propan-1-ol 
82 OH
 
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake above threshold, A4: Endogenous 
 
02.003 Isopentanol 
52 
OH  
Category 1 a) 
No safety concern d) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
02.004 Butan-1-ol 
85 
OH  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake above threshold, A4: Endogenous 
 
02.005 Hexan-1-ol 
91 
OH  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake above threshold, A4: Endogenous 
 
02.040 Pentan-1-ol 
88 OH
 
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
02.076 2-Methylbutan-1-ol 
1199 OH
 
Category 1 a) 
No safety concern e) 
Category B c) 
 
Class I 
A3: Intake below threshold 
 
02.078 Ethanol 
41 
OH  
Category 1 a) 
No safety concern d) 
 
 
 
No evaluation 
At the forty-sixth JECFA meeting (JECFA, 
1997a), the Committee concluded that ethanol 
posed no safety concern at its current level of 
intake when ethyl esters are used as 
flavouring agents. 
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Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
02.079 Isopropanol 
277 
OH
 
Category 1 a) 
No safety concern f) 
 
 
Class I 
A3: Intake above threshold, A4: Endogenous 
 
05.001 Acetaldehyde 
80 
O  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake above threshold, A4: Endogenous 
 
05.002 Propanal 
83 O
 
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
05.003 Butanal 
86 
O  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
05.004 2-Methylpropanal 
252 
O
 
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
05.005 Pentanal 
89 O
 
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake above threshold, A4: Endogenous 
 
05.006 3-Methylbutanal 
258 
O  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
05.008 Hexanal 
92 
O  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
05.009 Octanal 
98 
O  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
05.011 Dodecanal 
110 
O
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
05.021 Citronellal 
1220 
O  
 
No safety concern e) 
Category A c) 
 
Class I 
A3: Intake below threshold 
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Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
05.025 Nonanal 
101 
O  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
05.034 Undecanal 
107 
O  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
05.049 2-Methylbutyraldehyde 
254 O
 
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
05.075 Hex-3(cis)-enal 
316 O
 
 
No safety concern f) 
Category B c) 
 
Class I 
A3: Intake below threshold 
 
08.001 Formic acid 
79 
OHO  
Category 1 a) 
No safety concern b) 
Deleted c) 
 
Class I 
A3: Intake below threshold 
 
08.002 Acetic acid 
81 
O
OH  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake above threshold, A4: Endogenous 
 
1) Category 1: Considered safe in use   Category 2: Temporarily considered safe in use   Category 3: Insufficient data to provide assurance of safety in use   Category 4): Not acceptable due to evidence of toxicity. 
2) No safety concern at estimated levels of intake. 
3) Category A: Flavouring substance, which may be used in foodstuffs Category B: Flavouring substance which can be used provisionally in foodstuffs 
4) Threshold of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
5) Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot. 
a) (SCF, 1995). 
b) (JECFA, 1999b). 
c) (CoE, 1992). 
d) (JECFA, 1997a). 
e) (JECFA, 2004a). 
f) (JECFA, 2000a). 
ND: Not detected. 
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TABLE 3: SUPPORTING SUBSTANCES SUMMARY  
 
 Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
06.001 1,1-Diethoxyethane 
O
O 2002 
35 
105-57-7 
941 
JECFA specification (JECFA, 
2001c) 
200  
No safety concern a) 
Category A b) 
 
06.004 Citral diethyl acetal O
O
(E)-isomer shown
2304 
38 
7492-66-2 
948 
JECFA specification (JECFA, 
2001c) 
3.4  
No safety concern a) 
Category A b) 
GrADI: 0-0.5 (JECFA, 
1980a). 
06.005 Citral dimethyl acetal O
O
(E)-isomer shown
2305 
39 
7549-37-3 
944 
JECFA specification (JECFA, 
2001c) 
2.6  
No safety concern a) 
Category A b) 
 
06.008 1,1-Dimethoxyoctane 
O
O
 
2798 
42 
10022-28-3 
942 
JECFA specification (JECFA, 
2001c) 
0.97  
No safety concern a) 
Category A b) 
 
06.009 10,10-Dimethoxydecane 
O
O
 
2363 
43 
7779-41-1 
945 
JECFA specification (JECFA, 
2001c) 
0.024  
No safety concern a) 
Category B b) 
 
06.015 1,1-Dimethoxyethane 
O
O
 
3426 
510 
534-15-6 
940 
JECFA specification (JECFA, 
2001c) 
61  
No safety concern a) 
Category A b) 
 
06.025 1,1-Diethoxynona-2,6-diene 
O
O 3378 
660 
67674-36-6 
946 
JECFA specification (JECFA, 
2001c) 
0.037  
No safety concern a) 
Category B b) 
CASrn refers to 
(2Z,6Z)-isomer. 
06.028 1,1-Dimethoxyheptane 
O
O
 
2541 
2015 
10032-05-0 
947 
JECFA specification (JECFA, 
2001c) 
0.037  
No safety concern a) 
Category A b) 
 
06.033 1,1-Dibutoxyethane 
O
O  
2341 
871-22-7 
 
 
0.073  
 
Category A b) 
 
06.034 1,1-Dipropoxyethane 
O
O 4688 
2342 
105-82-8 
 
 
0.71  
 
Category A b) 
 
06.037 1,1-Diethoxyhept-4-ene (cis 
and trans) 
O
O
O
O 3349 
10011 
18492-65-4 
949 
JECFA specification (JECFA, 
2001c) 
0.037  
No safety concern a) 
 
CASrn refers to (Z)-
isomer. 
06.081 1-Ethoxy-1-(3-
hexenyloxy)ethane 
O
O
3775 
10034 
943 
JECFA specification (JECFA, 
4.6  
No safety concern a) 
Register name to be 
changed to 1-Ethoxy-1-
Flavouring Group Evaluation 3, Revision 2
 
 
34 EFSA Journal 2011; 9(10):2312 
 Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
28069-74-1 2002d)  (3Z-
hexenyloxy)ethane. 
Racemate of 1-Ethoxy-
1-(3Z-
hexenyloxy)ethane 
(EFFA, 2010a). 
1) EU MSDI: Amount added to food as flavouring substance in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Category 1: Considered safe in use, Category 2: Temporarily considered safe in use, Category 3: Insufficient data to provide assurance of safety in use, Category 4: Not acceptable due to evidence of toxicity. 
3) No safety concern at estimated levels of intake. 
4) Category A: Flavouring substance, which may be used in foodstuffs, Category B: Flavouring substance which can be used provisionally in foodstuffs. 
a) (JECFA, 2002b). 
b) (CoE, 1992). 
ND)  No intake data reported. 
 
 
Fla
 
 
35 EFSA Journal 2011; 9(10):2312 
ANNEX I: PROCEDURE FOR THE SAFETY EVALUATION 
The approach for a safety evaluation of chemically defined flavouring substances as referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), named the "Procedure", is shown in schematic 
form in Figure I.1. The Procedure is based on the Opinion of the Scientific Committee on Food expressed on 
2 December 1999 (SCF, 1999a), which is derived from the evaluation Procedure developed by the Joint 
FAO/WHO Expert Committee on Food Additives at its 44th, 46th and 49th meetings (JECFA, 1995; JECFA, 
1996a; JECFA, 1997a; JECFA, 1999b). 
The Procedure is a stepwise approach that integrates information on intake from current uses, structure-
activity relationships, metabolism and, when needed, toxicity. One of the key elements in the Procedure is 
the subdivision of flavourings into three structural classes (I, II, III) for which thresholds of concern (human 
exposure thresholds) have been specified. Exposures below these thresholds are not considered to present a 
safety concern. 
Class I contains flavourings that have simple chemical structures and efficient modes of metabolism, which 
would suggest a low order of oral toxicity. Class II contains flavourings that have structural features that are 
less innocuous, but are not suggestive of toxicity. Class III comprises flavourings that have structural 
features that permit no strong initial presumption of safety, or may even suggest significant toxicity (Cramer 
et al., 1978). The thresholds of concern for these structural classes of 1800, 540 or 90 microgram/person/day, 
respectively, are derived from a large database containing data on subchronic and chronic animal studies 
(JECFA, 1996a). 
In Step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The further steps 
address the following questions: 
• can the flavourings be predicted to be metabolised to innocuous products9 (Step 2)?  
• do their exposures exceed the threshold of concern for the structural class (Step A3 and B3)? 
• are the flavourings or their metabolites endogenous10 (Step A4)?  
• does a NOAEL exist on the flavourings or on structurally related substances (Step A5 and B4)? 
In addition to the data provided for the flavouring substances to be evaluated (candidate substances), 
toxicological background information available for compounds structurally related to the candidate 
substances is considered (supporting substances), in order to assure that these data are consistent with the 
results obtained after application of the Procedure.  
The Procedure is not to be applied to flavourings with existing unresolved problems of toxicity. Therefore, 
the right is reserved to use alternative approaches if data on specific flavourings warranted such actions. 
 
                                                     
 
9 “Innocuous metabolic products”: Products that are known or readily predicted to be harmless to humans at the 
estimated intakes of the flavouring agent” (JECFA, 1997a). 
 
10 “Endogenous substances”: Intermediary metabolites normally present in human tissues and fluids, whether free or 
conjugated; hormones and other substances with biochemical or physiological regulatory functions are not included 
(JECFA, 1997a). 
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Decision tree structural class 
Can the substance be predicted to be metabolised to innocuous products?
Procedure for Safety Evaluation of Chemically Defined Flavouring Substances 
Do the conditions of use result in an intake greater than the 
threshold of concern for the structural class?
Do the conditions of use result in an intake greater than the  
threshold of concern for the structural class? 
Data must be available on the  
substance or closely related  
substances to perform a safety 
evaluation
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is  high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
  Substance would not be    
expected to be of safety concern
Is the substance or are its metabolites endogenous?
Additional data required 
Step 1. 
Step 2. 
Step A3. 
Step A4. 
Step A5. 
Step B3. 
Step B4.
 Yes No
 Yes 
 No 
No
No
Yes
No
Yes
Yes
Yes
 No
Figure I.1 Procedure for Safety Evaluation of Chemically Defined Flavouring Substances
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ANNEX II: USE LEVELS / MTAMDI 
II.1 Normal and Maximum Use Levels 
For each of the 18 Food categories (Table II.1.1) in which the candidate substances are used, Flavour 
Industry reports a “normal use level” and a “maximum use level” (EC, 2000a). According to the Industry the 
”normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th 
percentile of reported usages (EFFA, 2002i). The normal and maximum use levels in different food 
categories have been extrapolated from figures derived from 12 model flavouring substances (EFFA, 2004e). 
Table II.1.1 Food categories according to Commission Regulation (EC) No 1565/2000 (EC, 2000a) 
Food category Description 
01.0 Dairy products, excluding products of category 02.0 
02.0 Fats and oils, and fat emulsions (type water-in-oil) 
03.0 Edible ices, including sherbet and sorbet 
04.1 Processed fruit 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds 
05.0 Confectionery 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding bakery 
07.0 Bakery wares 
08.0 Meat and meat products, including poultry and game 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  
10.0 Eggs and egg products 
11.0 Sweeteners, including honey 
12.0 Salts, spices, soups, sauces, salads, protein products, etc. 
13.0 Foodstuffs intended for particular nutritional uses 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts 
15.0 Ready-to-eat savouries 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 01.0 - 15.0 
 
The “normal and maximum use levels” are provided by Industry (EFFA, 2001c; EFFA, 2001d; EFFA, 
2002a; EFFA, 2002i; EFFA, 2003s; EFFA, 2007a; Flavour Industry, 2007a; Flavour Industry, 2011c) for the 
59 candidate substances in the present flavouring group (Table II.1.2). 
Table II.1.2.Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.03Rev2 (EFFA, 
2001c; EFFA, 2001d;  EFFA, 2002a; EFFA, 2002i;  EFFA, 2003s; EFFA, 2007a; Flavour Industry, 2007a; 
Flavour Industry, 2011c). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
03.023 0,00
5 
0,00
5 
- 
- 
0,01 
0,1 
- 
- 
- 
- 
0,00
5 
0,1 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0,01 
0,1 
- 
- 
0,00
2 
0,05 
0,00
3 
0,1 
0,01 
0,1 
0,00
5 
0,1 
06.041 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
06.042 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
06.043 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
60 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
10 
50 
06.044 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.045 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
06.046 7 5 10 7 - 10 5 10 2 2 - - 5 10 5 10 20 5 
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Table II.1.2.Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.03Rev2 (EFFA, 
2001c; EFFA, 2001d;  EFFA, 2002a; EFFA, 2002i;  EFFA, 2003s; EFFA, 2007a; Flavour Industry, 2007a; 
Flavour Industry, 2011c). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
35 25 50 35 - 50 25 50 10 10 - - 25 50 25 50 100 25 
06.047 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
06.048 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.049 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
- 
- 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.050 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
2 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
2 
25 
2 
10 
06.051 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.052 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.053 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.054 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.055 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
2 
25 
5 
10 
06.057 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.058 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.059 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
150 
2 
30 
5 
100 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
15 
4 
150 
5 
25 
2 
10 
06.061 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.062 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
3 
15 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.063 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
06.064 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.065 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.066 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
- 
- 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.067 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.069 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.070 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.071 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.073 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.074 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.075 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.076 - 
- 
2 
10 
3 
15 
3 
15 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.079 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.082 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.083 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
2 
25 
2 
10 
06.084 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.085 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.086 3 2 3 2 - 4 2 5 1 1 - - 2 3 2 4 2 2 
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Table II.1.2.Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.03Rev2 (EFFA, 
2001c; EFFA, 2001d;  EFFA, 2002a; EFFA, 2002i;  EFFA, 2003s; EFFA, 2007a; Flavour Industry, 2007a; 
Flavour Industry, 2011c). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
15 10 15 10 - 20 10 25 5 5 - - 10 15 10 20 25 10 
06.091 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.092 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.096 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
2 
10 
- 
- 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.100 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.105 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
06.106 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
20 
100 
5 
25 
10 
50 
- 
- 
5 
25 
06.107 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
06.109 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
06.111 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.114 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.115 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
06.123 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
06.124 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
06.125 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.127 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
- 
- 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.128 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.129 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
06.130 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.131 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
06.137 - 
- 
- 
- 
20 
30 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
20 
30 
20 
30 
- 
- 
- 
- 
II.2 mTAMDI Calculations 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values is 
based on the approach used by SCF up to 1995 (SCF, 1995). The assumption is that a person may consume 
the amount of flavourable foods and beverages listed in Table II.2.1. These consumption estimates are then 
multiplied by the reported use levels in the different food categories and summed up.  
Table II.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be consumed per 
person per day (SCF, 1995) 
Class of product category Intake estimate (g/day) 
Beverages (non-alcoholic) 324.0 
Foods 133.4 
Exception a: Candy, confectionery 27.0 
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Table II.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be consumed per 
person per day (SCF, 1995) 
Class of product category Intake estimate (g/day) 
Exception b: Condiments, seasonings 20.0 
Exception c: Alcoholic beverages 20.0 
Exception d: Soups, savouries 20.0 
Exception e: Others, e.g. chewing gum e.g. 2.0 (chewing gum) 
The mTAMDI calculations are based on the normal use levels reported by Industry. The seven food 
categories used in the SCF TAMDI approach (SCF, 1995) correspond to the 18 food categories as outlined in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a) and reported by the Flavour Industry in the 
following way (see Table II.2.2): 
• Beverages (SCF, 1995) correspond to food category 14.1 (EC, 2000a) 
• Foods (SCF, 1995) correspond to the food categories 1, 2, 3, 4.1, 4.2, 6, 7, 8, 9, 10, 13, and/or 16 
(EC, 2000a) 
• Exception a (SCF, 1995) corresponds to food category 5 and 11 (EC, 2000a) 
• Exception b (SCF, 1995) corresponds to food category 15 (EC, 2000a) 
• Exception c (SCF, 1995) corresponds to food category 14.2 (EC, 2000a) 
• Exception d (SCF, 1995) corresponds to food category 12 (EC, 2000a) 
• Exception e (SCF, 1995) corresponds to others, e.g. chewing gum. 
Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation (EC) No1565/2000 Distribution of the seven SCF food categories 
Key Food category Food Beverages Exceptions 
01.0 Dairy products, excluding products of category 02.0 Food   
02.0 Fats and oils, and fat emulsions (type water-in-oil) Food   
03.0 Edible ices, including sherbet and sorbet Food   
04.1 Processed fruit Food   
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), 
and nuts & seeds 
Food   
05.0 Confectionery   Exception a 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & 
legumes, excluding bakery 
Food   
07.0 Bakery wares Food   
08.0 Meat and meat products, including poultry and game Food   
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  Food   
10.0 Eggs and egg products Food   
11.0 Sweeteners, including honey   Exception a 
12.0 Salts, spices, soups, sauces, salads, protein products, etc.    Exception d 
13.0 Foodstuffs intended for particular nutritional uses Food   
14.1 Non-alcoholic ("soft") beverages, excl. dairy products  Beverages  
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts   Exception c 
15.0 Ready-to-eat savouries   Exception b 
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Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation (EC) No1565/2000 Distribution of the seven SCF food categories 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be 
placed in categories 01.0 - 15.0 
Food   
 
The mTAMDI values (see Table II.2.3) are presented for each of the 59 flavouring substances in the present 
flavouring group, for which Industry has provided use and use levels (EFFA, 2001c; EFFA, 2001d; EFFA, 
2002a; EFFA, 2002i; EFFA, 2003s; Flavour Industry, 2007a; Flavour Industry, 2011c). The mTAMDI 
values are only given for the highest reported normal use levels. 
TableII.2.3 Estimated intakes based on the mTAMDI approach 
FL-no EU Register name mTAMDI 
(μg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
03.023 1-Ethoxyethyl acetate 2.6 Class I 1800 
06.041 1-Isobutoxy-1-ethoxy-2-methylpropane 3900 Class I 1800 
06.042 1-Isobutoxy-1-ethoxy-3-methylbutane 3900 Class I 1800 
06.043 1-Isoamyloxy-1-ethoxypropane 3900 Class I 1800 
06.044 1-Isobutoxy-1-ethoxypropane 1600 Class I 1800 
06.045 1-Isobutoxy-1-isopentyloxy-2-methylpropane 3900 Class I 1800 
06.046 1-Isobutoxy-1-isopentyloxy-3-methylbutane 3900 Class I 1800 
06.047 1-Isopentyloxy-1-propoxyethane 3900 Class I 1800 
06.048 1-Isopentyloxy-1-propoxypropane 1600 Class I 1800 
06.049 1-Butoxy-1-(2-methylbutoxy)ethane 1600 Class I 1800 
06.050 1-Butoxy-1-ethoxyethane 1300 Class I 1800 
06.051 1,1-Di-(2-methylbutoxy)ethane 1600 Class I 1800 
06.052 1,1-Di-isobutoxy-2-methylpropane 1600 Class I 1800 
06.053 1,1-Di-isobutoxyethane 1600 Class I 1800 
06.054 1,1-Di-isobutoxypentane 1600 Class I 1800 
06.055 1,1-Di-isopentyloxyethane 1600 Class I 1800 
06.057 1,1-Diethoxy-2-methylbutane 1600 Class I 1800 
06.058 1,1-Diethoxy-2-methylpropane 1600 Class I 1800 
06.059 1,1-Diethoxy-3-methylbutane 1600 Class I 1800 
06.061 1,1-Diethoxybutane 1600 Class I 1800 
06.062 1,1-Diethoxydodecane 1700 Class I 1800 
06.063 1,1-Diethoxyhex-3-ene 3900 Class I 1800 
06.064 Diethoxymethane 1600 Class I 1800 
06.065 1,1-Diethoxynonane 1600 Class I 1800 
06.066 1,1-Diethoxyoctane 1600 Class I 1800 
06.067 1,1-Diethoxypentane 1600 Class I 1800 
06.069 1,1-Diethoxypropane 1600 Class I 1800 
06.070 1,1-Diethoxyundecane 1600 Class I 1800 
06.071 1,1-Dihexyloxyethane 1600 Class I 1800 
06.073 1,1-Dimethoxyhexane 1600 Class I 1800 
06.074 Dimethoxymethane 1600 Class I 1800 
06.075 1,1-Dimethoxypentane 1600 Class I 1800 
06.076 1,1-Dimethoxypropane 1600 Class I 1800 
06.079 1-Ethoxy-1-(2-methylbutoxy)ethane 1600 Class I 1800 
06.082 1-Ethoxy-1-hexyloxyethane 1600 Class I 1800 
06.083 1-Ethoxy-1-isopentyloxyethane 1600 Class I 1800 
06.084 1-Ethoxy-1-methoxyethane 1600 Class I 1800 
06.085 1-Ethoxy-1-pentyloxyethane 1600 Class I 1800 
06.086 1-Ethoxy-1-propoxyethane 1600 Class I 1800 
06.091 1-Isobutoxy-1-ethoxyethane 1600 Class I 1800 
06.092 1-Isobutoxy-1-isopentyloxyethane 1600 Class I 1800 
06.100 1,1-Dipentyloxyethane 1600 Class I 1800 
06.105 3-Methyl-1,1-di-isopentyloxybutane 3900 Class I 1800 
06.106 2-Methyl-1,1-di-isopentyloxypropane 4900 Class I 1800 
06.107 1-(2-Methylbutoxy)-1-isopentyloxyethane 3900 Class I 1800 
06.109 1,1-Diethoxy-3,7-dimethyloct-6-ene 3900 Class I 1800 
06.111 1-Ethoxy-1-methoxypropane 1600 Class I 1800 
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TableII.2.3 Estimated intakes based on the mTAMDI approach 
FL-no EU Register name mTAMDI 
(μg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
06.114 1-Hexyloxy-1-isopentyloxyethane 1600 Class I 1800 
06.115 1-Isopentyloxy-1-pentyloxyethane 3900 Class I 1800 
06.123 1-Butoxy-1-isopentyloxyethane 3900 Class I 1800 
06.124 1,1-Di-isobutoxy-3-methylbutane 3900 Class I 1800 
06.125 1,1-Di-isobutoxypropane 1600 Class I 1800 
06.127 1-Ethoxy-1-isopentyloxypropane 1600 Class I 1800 
06.128 1-Ethoxy-1-pentyloxybutane 1600 Class I 1800 
06.129 1-Ethoxy-2-methyl-1-isopentyloxypropane 3900 Class I 1800 
06.130 1-Ethoxy-2-methyl-1-propoxypropane 1600 Class I 1800 
06.131 1-Ethoxy-1-(3-methylbutoxy)-3-methylbutane 1600 Class I 1800 
06.137 Acetaldehyde ethyl isopropyl acetal 9500 Class I 1800 
06.096 Triethoxymethane 1600 Class III 90 
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ANNEX III: METABOLISM 
III.1. Absorption, Distribution and Elimination 
The 59 acetals derived from aliphatic, saturated, acyclic alcohols and saturated or monounsaturated 
aldehydes, the orthoester of formic acid and the ester of a hemiacetal in the present Flavouring Group 
Evaluation are predicted to by hydrolysed in the gastrointestinal tract. The hydrolysis products are all 
relatively simple alcohols and aldehydes, which may be assumed to be rapidly absorbed and metabolised. 
There are only few data on absorption, distribution and excretion available for the candidate and supporting 
substances:  
Dogs were treated with 1, 1.5 or 2 ml paraldehyde/kg body weight (bw) and subsequently kept in 
metabolism cages. Urine and expired air were analysed for paraldehyde. Pulmonary excretion of paraldehyde 
amounted to 11 to 28 % of the dose, while urinary excretion amounted to 0.1 to 2.5 % of the dose, indicating 
that about 70 to 88 % of the dose had been metabolised (faeces and tissues not studied). In dogs in which 
liver damage was induced by pre-treatment with chloroform, the pulmonary elimination of paraldehyde was 
considerably increased. In these animals, renal elimination of paraldehyde was hardly affected. In animals 
without liver damage, the concentration of paraldehyde in the expired air decreased with a half-life of 
roughly four to five hours (Levine et al., 1940). The analytical methods in this study do not discriminate 
between paraldehyde and acetaldehyde. However, if it is assumed that acetaldehyde is rapidly incorporated 
in the normal metabolism, it can be concluded that up to 90 % of an oral dose of paraldehyde is metabolised.  
Paraldehyde was administered at different dose levels, either orally or via i.p. injection, to normal and carbon 
tetrachloride-pretreated mice. Pulmonary elimination of paraldehyde (0.25 to 1 g/kg bw; i.p or p.o.) 
amounted to ca 4 - 10 % of the dose in normal mice, whereas CCl4-pretreated animals excreted 27 to 30 % of 
the dose (0.25 or 0.5 g/kg bw; i.p. or p.o.). At lower dose levels (0.05 to 0.1 g/kg bw; i.p. or p.o.) the total 
amount excreted via the lungs amounted 1.5 to 5 % in normal animals, while CCl4-pretreated mice exhaled 3 
- 5 % after an oral dose (0.05 or 0.1 g/kg bw) or 6 - 26  % after i.p. administration. In addition, at higher dose 
levels and after pre-treatment with CCl4, exhalation of paraldehyde took more time than at lower dose levels 
(several hours vs. one hour), which finding was also reflected in retarded blood and total body clearance of 
paraldehyde. No acetaldehyde could be determined in the exhaled air of mice that were treated with 
paraldehyde. Exhalation of acetaldehyde by animals treated with acetaldehyde (p.o. or i.p.) showed a very 
rapid decrease in time, which was independent of pre-treatment with CCl4. The data indicate that the 
hydrolysis of paraldehyde is the rate-limiting step in the elimination of this substance, and that the liver 
contributes to a major extent to this hydrolysis. In addition, the elimination rate is saturable at high dose 
levels of paraldehyde (> 0.25 g/kg bw) (Hitchcock and Nelson, 1943). 
Serum levels of paraldehyde were assessed in five children who had received paraldehyde by i.m. injection 
as treatment of epileptic convulsions. This study reports blood-concentration-time curves for paraldehyde. 
After a rapid increase in blood levels, shortly after injection, paraldehyde was eliminated from the blood with 
an average half-life of 7.5 hours. Paraldehyde in the blood was determined after treatment of blood samples 
with 0.1 N HCl at 100ºC for 15 minutes to convert it completely to acetaldehyde, which was quantified by 
measuring NADH oxidation linked to enzyme-catalysed acetaldehyde reduction. No information on 
acetaldehyde levels in non-acid treated blood samples was gathered, but if it is assumed that acetaldehyde is 
rapidly incorporated in the normal physiology of the body, the study shows that paraldehyde is only slowly 
hydrolysed in biological tissues. In the children, the i.m. treatment with paraldehyde (0.25 or 0.33 ml/kg bw 
of a solution containing 0.2 mg/ml) caused narcosis (Thurston et al., 1968). 
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III.2. Biotransformation 
Acetals are stable in neutral or basic environment, but when treated with aqueous acid they are hydrolysed 
and reconverted to alcohol and aldehyde (Streitwieser et al, 1992; Carey, 1992; Carey and Sundberg, 1990; 
Vollhardt, 1988; Sykes, 1982; Beyer and Walter, 1984). 
The hydrolysis of acetals may occur either as a specific acid catalysed hydrolysis or as a general acid 
catalysed hydrolysis. The hydrolysis rate is clearly influenced by the nature of substituents on the carbonyl 
moiety. Electron-donor substituents on the carbon atom of the acetal group accelerate hydrolysis, while 
electron-acceptor substituents slow hydrolysis. Generally, there is an increase in hydrolysis rate with a higher 
degree of substitution at the central carbon atom at each functional group, and when a hydrocarbon atom is 
replaced by an alkyl or an alkoxy group (Deslongchamps et al., 2000; Kreevoy and Taft, 1955a; Pchelintsev 
et al., 1988).  
Ethoxy compounds are hydrolysed four to nine times faster than the corresponding methoxy derivatives 
because the ethoxy group is more basic (more readily protonated) than the methoxy group and therefore a 
better leaving group. Some increase in rate was observed as a result of lengthening or branching of the 
alcohol molecule chain, some increase in rate is also found by changing from a primary alcohol to a 
secondary alcohol. These experiments were executed with acetals in dioxolane-water (49.6 – 50.4 %) 
solution (Pchelintsev et al., 1988). The hydrolysis of acetals in aqueous solution containing in their molecule 
two to eight oxyethylene units and three alkyl groups of varying lengths was examined by Sokolowski & 
Burczyk, (1979). Considerable differences were found in reaction rates between acetals obtained from 
acetaldehyde and from formaldehyde, with the former having the greater reaction rate. The increase in size of 
alkyl groups derived from aldehyde moiety in one acetal series resulted in a small reduction of acetal 
stability in water. The size of alkyl groups in the alcohol moiety and the number of oxyethylene groups have 
a small effect on rate constants (Sokolowski and Burczyk, 1979).  
In vitro experiments using simulated gastric fluid revealed the rates of hydrolysis of acetals to be dependent 
on the structures of the aldehyde and alcohol moieties. Acetals derived from short straight chain saturated 
aldehydes, up to C8 were hydrolysed instantly. For decanal-derived homologues (diethyl and dimethyl 
acetals) half-lives in the order of 30 minutes were observed (Engel, 2003). On the basis of structural 
similarity these data indicate that the candidate acetals can be predicted to be hydrolysed. 
A few studies demonstrate that acetals may be hydrolysed enzymatically in microsome preparations and 
studies on conversion rate of the cyclic acetal paraldehyde to acetaldehyde show that liver may contribute to 
hydrolysis to a major extent after oral intake or i.p. injection, but that hydrolysis also takes place in other 
biological tissues. The process may however be slow and incomplete (Edsbacker et al., 1987; Levine et al., 
1940; Hitchcock and Nelson, 1943; Thurston et al., 1968). 
III.2.1. Hydrolysis of Acetals 
Hydrolysis data from studies referred to below are summarised in Table III.1.  
In vitro – acid hydrolysis of acetals   
Hydrolysis of four acetals in simulated gastric juice (pH 1.2) and simulated intestinal fluid (pH 7.5) was 
monitored by the formation rate of aldehyde liberated during treatment. 1,1-Diethoxyethane (DEE), 
hydroxy-citronellal-dimethyl-acetal (8,8-dimethoxy-2,6-dimethyl-2-octanol, DDO) and hydrotropic 
aldehyde dimethyl acetal (1,1-dimethoxy-2-phenylpropane, DMPP) were completely hydrolysed after one 
hour in simulated gastric juice at 37°C. However, benzaldehyde propylene glycol acetal (4-methyl-2-phenyl-
1,3-dioxolane, MPD) was only hydrolysed to an extent of around 50 % after one hour in simulated gastric 
juice and no further hydrolysis was observed after five hours. Reflux of MPD for five hours in 0.1N HCl also 
resulted in hydrolysis to an extent of 50 % of the theoretical maximum. Due to the same poor hydrolysis of 
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MPD (to around 50 % again) even after five hours reflux in 0.1 N HCl the author questioned the chemical 
identity of the sample (Morgareidge, 1962a). Accordingly, these data on hydrolysis of MPD are rather 
inconclusive. 
In simulated intestinal fluid 5 - 10 % hydrolysis was observed with DEE, DDO or DMPP after five hours. 
With MPD about 17 % of the substance was hydrolysed after the same period of time (Morgareidge, 1962a). 
Sokolowski and Burczyk studied the hydrolysis of acetals formed from aliphatic aldehydes and monoalkyl 
ethers of ethylene glycols. Hydrolysis was carried out in 1 M HCl at either 50ºC or 20ºC. The T½ of the 
acetals varied from about six to 27 minutes. The data indicated that the rate of hydrolysis increases with 
increasing length of the carbon chain at the aldehyde part of the molecule as well as at the ether part of the 
molecule. Results are summarised in Table III.2 (Sokolowski and Burczyk, 1979). 
Potassium 2-(1'-ethoxy)ethoxypropanoate (PEEP), the salt of an acetal of lactic acid, was designed to 
hydrolyse to acetaldehyde when used in beverage and dessert powders, and to hydrolyse at a greater rate than 
1,2-di[(1'-ethoxy)ethoxy]propane (DEEP) (FEMA No. 3534). The hydrolysis of PEEP in simulated stomach 
fluid showed 100 % hydrolysis in ten minutes (pH 2.4, 37°C). PEEP was shown to release acetaldehyde 
quicker than DEEP at pH 3 and 25°C (Moreno et al., 1984). 
A comparative study of the regeneration of citral from the corresponding dimethyl and propylene glycol 
acetals (CDMA and CPGA respectively) under mild acidic conditions showed that, although the former 
decomposed to an extent of 85 % in 15 minutes, the latter formed a near 1:1 equilibrium mixture with the 
generated aldehyde. The conditions employed for the decomposition of CDMA and CPGA were catalytic 
amounts of 1:1 aqueous HCl in acetone medium at 65°C. CPGA failed to undergo complete cleavage even 
under drastic conditions of refluxing with 10 % phosphoric acid, which indicated the remarkable stability of 
the five-membered 1,3-dioxolane ring with substituents at positions 2 and 4. The conclusion of the authors 
was that propyleneglycol acetals were not suitable as aldehydic flavourings because the aldehydes could be 
only partly recovered under normal hydrolytic conditions (Sharma et al., 1998). 
In a similar in vitro study hydrolysis of three acetals 1,2,3-tris((1'-ethoxy)-ethoxy)propane (TEEP), 1,2-di[ 
(1'-ethoxy)-ethoxy]propane (DEEP) and 4-(1'-ethoxy)ethoxymethyl-2-methyl-1,3-dioxolane (EEMMD) was 
monitored by the formation rate of acetaldehyde liberated during treatment in simulated gastric juice and 
simulated gastric juice without pepsin, pH 1.2 and temperature 37°C. The rate of hydrolysis was determined 
by comparison of the liberated amount of acetaldehyde with the theoretical maximal amount that could be 
produced. TEEP and DEEP were completely hydrolysed within 30 minutes. EEMMD was hydrolysed for 
about 60 % after 15 minutes and for about 80 % after one hour. The remainder of the acetaldehyde was 
liberated during the next two hours. It was speculated for EEMMD that the first rapid part of the hydrolysis 
represented mainly the hydrolysis of the linear acetal part of the molecule, while the slower second part of 
the degradation reflected the hydrolysis of the cyclic dioxolane moiety (DeSimone, 1976). 
In vitro – enzymatic hydrolysis of acetals 
One study has been conducted on hydrolysis of 2-propylpentanal acetals by liver microsomes in vitro. A 
study was conducted on the feasibility of using acetals of 2-propylpentanal as pro-drugs in valproic acid (2-
propylpentanoic acid) treatment. Incubation of dimethoxy, or dipropoxy derivatives of 2-propylpentanal with 
either rat liver 10000 g supernatant or rat liver microsomes yielded 2-propylpentanoic acid or 2-propyl 
pentanol. The formation rate of 2-propyl pentanol and 2-propylpentanoic acid from diethoxy-2-
propylpentane was greatly reduced when deficient or defective microsomal systems were used. However, the 
study did not demonstrate that the hydrolysis of the acetals was solely mediated by cytochrome P-450 
enzymes, because even in the deficient/defective systems some formation of free acid or alcohol did occur. 
In addition, the observation that in 100000 g supernatant systems, 2-propylpentanol was formed from 
diethoxy-2-propylpentane also show that the hydrolysis of this acetal is not completely dependent on 
cytochrome P-450 activity. Incubation of 1,1-diethoxy-3-phenyl propane yielded 3-phenyl propanoic acid, 3-
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phenyl propanal and 3-phenyl propanol. The acid and alcohol derivatives of 2-propylpentanal were identified 
in the supernatant and microsomal fractions of rat liver incubated with 1 micro-mol of dimethyl, diethyl or 
di-isopropyl acetals of 2-propylpentanal (Vicchio and Callery, 1989). 
In a similar study the topical glucocorticoid budesonide (16,17-butylidenedioxy-11,21-dihyroxypregna-1,4-
diene-3,20-dione) was incubated with S-9 fractions from human liver, liver from male Sprague-Dawley rats, 
or liver from NMRI mice. Budesonide is chemically stable against non-enzymatical hydrolysis. A 
16alfa,17alfa-acetal splitting was shown to occur in all three liver preparations. The conclusion drawn is that 
the systemic inactivation of budesonide is rapid due to extensive liver biotransformation, and that the acetal 
splitting of budesonide increases the overall rate of inactivation and may therefore reduce the risk of 
systemic side effects when using the drug topically (Edsbacker et al., 1987). 
In vivo biotransformation of acetals 
A few studies have been conducted in vivo on biotransformation (and excretion) of paraldehyde, the cyclic 
acetal formed from three molecules of acetaldehyde, which has been used as a hypnotic.  
Rats and rabbits were dosed with acetals by i.p. injection or by gavage, respectively. The following acetals 
were studied: dimethoxymethane (DMM), diethoxymethane (DEM), di-(1-propoxy)methane (D1PM), di-(2-
propoxy)methane (D2PM), di-(1-butoxy)methane (DBM), dimethoxyethane (DME), diethoxyethane (DEE), 
1,1-diethoxypropane (11DEP), 2,2-diethoxypropane (22DEP), 2,2-diethoxyethanol (DEOH), 1,1,2-
triethoxyethane (TrEE), 1,1,2,2-tetraethoxyethane (TeEE), triethoxymethane (TEM) and 2,4,6-trimethyl-
1,3,5-trioxane (TMT). The studied effects in the animals were sleeping time (rats), posture changes (rabbits) 
and death (both species). The effects in rabbits occurred at higher dose levels than those in rats, possibly 
indicating an effect of dosing route, and possibly species sensitivity. Velocity constants for acid hydrolysis 
of the acetals were provided. Within the group of five methanal-derived acetals (DMM, DEM, D1PM, 
D2PM and DBM), the rate constants varied with 1-2 orders of magnitude, depending on alcohol chain length 
and position of hydroxyl group. For these methanal derivatives, the rate constants were 4-5 orders of 
magnitude less than for one ethanal-derived acetal (DEE). The hydrolysis rate constants for the one 
orthoester (TEM) and the ketal (22DEP) were about 2-3 orders higher than that of DEE. These findings 
indicate that rates of acetal acid hydrolysis may vary considerably, depending on molecular structure, even 
within this group of closely related substances (Knoefel, 1934). 
It is also indicated in the above studies (Hitchcock and Nelson, 1943; Levine et al., 1940; Thurston et al., 
1968), that in vivo hydrolysis of acetals may take place. 
III.2.2. Hydrolysis of orthoesters 
Orthoesters may be hydrolysed either by specific or by general hydrolysis (Kankaanperä and Lahti, 1970; 
Lahti and Kankaanperä, 1970). Like acetals, orthoesters that possess a good leaving group and are able to 
form stable oxo-carbonium ion intermediates show pronounced general acid catalysis (Anderson and Fife, 
1972). Simple orthoesters such as triethyl orthoformate (triethoxymethane, [FL-no: 06.096]) undergo 
specific acid hydrolysis in water (Bunton and De Wolfe, 1965; Cordes and Bull, 1974). 
In the study by Knoefel (Knoefel, 1934) (see above) the orthoester triethoxymethane [FL-no: 06.096] as well 
as several acetals were administered to rats i.p. and to rabbits by gavage in amounts great enough to give 
anaesthesia, which for most of the tested compounds were close to the lethal dose. For the orthoester, as well 
as for some of the acetals, there was a difference in duration of narcotic activity between rats and rabbits, 
with less activity in rabbits. The authors reasoned that the relative inactivity of the orthoester, as well as of 
some acetals, was due to decomposition by acid hydrolysis in the stomach of the rabbits. Comparisons of 
velocity constants of acid hydrolysis of the acetals and the orthoester were made, indicating that the large 
differences in velocity constants could explain differences in activity. It was also concluded that compounds 
with reduced solubility in water had an uncertain and weak narcotic action. 
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III.3. Fate of Hydrolysis Products 
At low levels of exposure, the hydrolysis products from the 57 acetals, the orthoester and the ester of a 
hemiacetal are rapidly absorbed, distributed, and metabolised to carbon dioxide and water. At higher dose 
levels, minor amounts of low molecular weight alcohols and aldehydes may be excreted via exhaled air or in 
the urine.  
In general, linear aliphatic acyclic alcohols (DeBruin, 1976; Lington and Bevan, 1994) and aldehydes 
(Brabec, 1993) and branched-chain aliphatic acyclic alcohols and aldehydes (Gaillard and Derache, 1965; 
Dawson et al., 1964a) are absorbed from the gastrointestinal tract, and rapidly eliminated from the blood 
primarily by metabolism in the liver. Plasma half-lives are normally difficult to measure since some low 
molecular weight alcohols (e.g., ethanol) and aldehydes (e.g., ethanal) are endogenous in humans (Lington 
and Bevan, 1994).   
Based on experimental data, it may be concluded that simple aliphatic linear and branched-chain alcohols are 
rapidly absorbed, completely metabolised, and excreted within 24 hours. At very high dose levels, small 
amounts of the alcohol or its metabolite may be detected in the urine. 
The component alcohols (or acetic acid) and the saturated and monounsaturated aldehydes (or formic acid) 
formed from this group of acetals (and one orthoester and one ester of a hemiacetal) are all metabolised by 
well-recognised pathways. The alcohols are oxidised by alcohol dehydrogenase to yield the corresponding 
aldehyde that may be further oxidised by aldehyde dehydrogenase or various oxidases to yield the 
corresponding carboxylic acids. The linear carboxylic acids then enter the fatty acid pathway in which they 
undergo beta-oxidation and cleavage to yield either propionyl coenzyme A (CoA) or acetyl coenzyme A. 
These CoA substrates are completely oxidised to carbon dioxide and water in the tricarboxylic acid cycle. 
The branched chain carboxylic acids also undergo beta-oxidation preferably in the longer chain to yield 
linear acid fragments that also become substrates for oxidation in the fatty acid pathway or tricarboxylic acid 
cycle. The three branched chain carboxylic acids, isobutyric, 2-methylbutyric, and 3-methylbutyric acids, 
formed from alcohols and aldehydes in this group are endogenous in humans as products of the oxidative de-
amination of the amino acids valine, isoleucine and leucine, respectively (Michal, 1999a). 
III.4. Conclusion 
Data indicate that hydrolysis of acetals, the orthoester [FL-no: 06.096] and the ester of a hemiacetal [FL-no: 
03.023] of the present Flavouring Group Evaluation (FGE.03Rev2) may occur in vitro, as well as in vivo 
under acidic circumstances. In addition, enzymatic cleavage of acetals and further metabolism has been 
observed in vitro as well as in vivo. At least part of this enzymatic cleavage and metabolism capacity is 
located in the liver. The data from studies on hydrolysis in vitro as well as the in vivo studies show that the 
time for hydrolysis may vary greatly even within groups of very closely related substances. Hydrolysis data 
on compounds with structural similarity to the candidate substances show that the candidate acetals may be 
predicted to be hydrolysed. However, it cannot be excluded that some amounts of the parent acetals may 
reach the systemic circulation. From experimental studies it is indicated that acetals may be hydrolysed 
enzymatically by liver microsomes and that hydrolysis also may take place in other tissues. 
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Results on hydrolysis studies abstracted in section III.2. 
 
TABLE III.1        
Name 
FL-, JECFA-no 
Structure 
Test System Results Hydrolysis Vmax Km Reference Evaluation 
status T½ % Hydrolysis 
(after hours) 
Chemical Enzymatic 
in vivo//in vitro 
1,1-Diethoxyethane (DEE) 
[06.001], 941 
 
O
O
 
 
Art. gastric juice; pH = 
1.2. 
 Ca. 90 % after 1 
h; no further 
increase after 5 h.  
    (Morgareidge, 
1962a) 
JECFA 
(JECFA, 
2002b) 
CoE Cat. A 
(CoE, 1992) 
Art. pancreat. juice; pH 
= 7.5. 
 Ca. 6 % after 1 h; 
ca 10 % after 5 h. 
    (Morgareidge, 
1962a) 
In vivo in rabbits dosed 
by gavage. 
    ‘Considerable 
amounts’ excreted by 
pulmonary excretion 
(no quantitative data). 
 (Knoefel et al., 
1932) 11 
In vivo  
Rats dosed i.p. 
Rabbits dosed by 
gavage. 
     Rate constant for 
acid hydrolysis in 
vitro (system not 
known) 15.0. 
(Knoefel, 1934) 
12 
8,8-Dimethoxy-2,6-dimethyl-2-octanol 
(DDO) 
1,1-dimethoxy-3,7-dimethyloctan-7-ol 
[06.011], 612 
 
O
O
OH
 
 
Art. gastric juice; pH = 
1.2 
 Ca. 100 % after 1 
h. 
    (Morgareidge, 
1962a) 
JECFA 
(JECFA, 
2000b) 
CoE Cat. A 
(CoE, 1992) 
Art. pancreat. juice; pH 
= 7.5. 
 Ca. 3 % after 1 h; 
ca 5 % after 5 h. 
    (Morgareidge, 
1962a) 
1,1-Dimethoxy-2-phenylpropane (DMPP) 
[06.030] 
 
O
O
 
 
Art. gastric juice; pH = 
1.2. 
 Ca. 97 % after 1 
h. 
    (Morgareidge, 
1962a) 
CoE Cat. B 
(CoE, 1992) 
Art. pancreat. juice; pH 
= 7.5. 
 Ca. 5 % after 1 h; 
no further 
increase after 5 h. 
    (Morgareidge, 
1962a) 
                                                     
 
11 It is stated that the rates and duration of action are equal for the compounds when given in doses of equal effectiveness (hypnotic effect). This is what is stated as far as rates. All substances were excreted by the lungs in considerable amounts. 
12 In the study it is stated that route of administration is of importance, especially for the ethanals  - ip do ethanals have half hypnotic activity as compared to methanals, po much less effect. For the methanals, the activity increases with chain 
length at first, but then with less solubility activity becomes uncertain and very low with butoxy-methanals. The propanals have low solubility and therefore uncertain (and low) activity. 
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TABLE III.1        
Name 
FL-, JECFA-no 
Structure 
Test System Results Hydrolysis Vmax Km Reference Evaluation 
status T½ % Hydrolysis 
(after hours) 
Chemical Enzymatic 
in vivo//in vitro 
4-Methyl-2-phenyl-1,3-dioxolane (MPD) 
[06.032], 839 
 
O
O  
art. gastric juice; pH = 
1.2. 
 Ca. 52 % after 1 
h; no further 
increase after 5 h. 
    (Morgareidge, 
1962a) 
JECFA 
(JECFA, 
2002b) 
CoE Cat. A 
(CoE, 1992) 
Art. pancreat. juice; pH 
= 7.5. 
 Ca. 17 % after 1 
h; no further 
increase after 5 h. 
    (Morgareidge, 
1962a) 
 
 
1,2,3-Tris((1'-ethoxy)-ethoxy)propane 
(TEEP) 
[06.040], 913 
 
O
O
O
O
O
O
 
 
art. gastric juice; pH = 
1.2. 
 Complete within 
30 min. 
    (DeSimone, 
1976) 
JECFA 
(JECFA, 
2002b) 
1,2-Di((1'-ethoxy)-ethoxy)propane 
(DEEP)  
[06.039], 927 
 
O
O
O
O
 
 
Art. gastric juice; pH = 
1.2. 
 Complete within 
30 min. 
    (DeSimone, 
1976) 
 
4-(1’-Ethoxy)ethoxymethyl-2-methyl-1,3-
dioxolane (EEMMD) 
 
O
O
O O
 
 
Art. gastric juice; pH = 
1.2. 
 61 % within 15 
min (all of the 
linear part); 
complete within 
120 min. 
    (DeSimone, 
1976) 
 
1,1-Dimethoxy-2-propylpentane 
O
O  
 
Rat liver 10000g 
supernatant with 
NADPH for 15 min. 
   Hydrolysis observed, 
but quantitative data 
not presented. 
  (Vicchio and 
Callery, 1989) 
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TABLE III.1        
Name 
FL-, JECFA-no 
Structure 
Test System Results Hydrolysis Vmax Km Reference Evaluation 
status T½ % Hydrolysis 
(after hours) 
Chemical Enzymatic 
in vivo//in vitro 
1,1-Diethoxy-2-propylpentane 
 
O
O  
 
Rat liver 10000g 
supernatant with 
NADPH for 15 min. 
   47 % per gram liver 
per 15 min. 
  (Vicchio and 
Callery, 1989) 
13 
 
Rat liver microsomes 
with NADPH for 15 min 
   41 % per gram liver 
per 15 min. 
  (Vicchio and 
Callery, 1989) 
 
1,1-Di-isopropoxy–2-propylpentane 
 
O
O
 
 
Rat liver 10000g 
supernatant with 
NADPH for 15 min. 
   Hydrolysis observed, 
but quantitative data 
not presented. 
  (Vicchio and 
Callery, 1989) 
 
1,1-Diethoxy-3-phenylpropane 
 
O
O  
 
Rat liver microsomes 
with NADPH with or 
without 100000 g 
supernatant. 
   Hydrolysis observed, 
but quantitative data 
not presented. 
  (Vicchio and 
Callery, 1989) 
 
                                                     
 
13 Tabulated data are calculated from the results presented in the study. % of hydrolysis refers to the amount of acetal that was present in the incubations. For supenatants, formation rate of free propyl-pentanoic acid was determined, for 
microsomes, hydrolysis rate was determined by formation of prolyl pentanol. In the paper, proten concentrations in the incubates were expressed as “per gram liver”.  
Flavouring Group Evaluation 3, Revision 2
 
 
51 EFSA Journal 2011; 9(10):2312 
TABLE III.1        
Name 
FL-, JECFA-no 
Structure 
Test System Results Hydrolysis Vmax Km Reference Evaluation 
status T½ % Hydrolysis 
(after hours) 
Chemical Enzymatic 
in vivo//in vitro 
2,4,6-Trimethyl-1,3,5-trioxane (TMT) 
(paraldehyde) 
[05.053] 
 
O O
O
 
In vivo in dogs, dosed 
by stomach tube. 
For 
pulmonary 
excretion : 
4-5 h. 
  70 - 88 % of the 
dose metabolised.  
  (Levine et al., 
1940) 14 
SCF Cat. 1 
(SCF, 1995) 
CoE Cat. A 
(CoE, 1992) 
In vivo in dogs, dosed 
by stomach tube; 
pretreated with 
chloroform. 
For 
pulmonary 
excretion: 
12-14 h. 
  60 - 80 % of the 
dose metabolised.  
  (Levine et al., 
1940) 14 
 
In vivo in mice, dosed 
p.o or i.p. 
 
 
   Total amount 
metabolised 99 - 90 
% (decreasing with 
increasing dose 
level). 
Pulmonary excretion of 
parent compound: 1.5 
to 10 % of the dose; 
pulmonary excretion 
increases with 
increasing dose. 
 
 (Hitchcock and 
Nelson, 1943) 
15 
 
In vivo in mice, dosed 
p.o or i.p. after carbon 
tetrachloride pre-
treatment. 
   Total amount 
metabolised 97 - 72 
% (decreasing with 
increasing dose level 
of paraldehyde). 
Pulmonary excretion of 
parent compound: 3 to 
30 % of the dose; 
pulmonary excretion 
increases with 
increasing dose. 
 
 (Hitchcock and 
Nelson, 1943) 
 
Children in vivo, i.m. 
administration. 
Plasma 
half-life of 
paraldehyd
e: 7.5 h. 
     (Thurston et al., 
1968) 
 
In vivo in rabbits dosed 
by gavage. 
 
    Considerable amounts 
excreted by pulmonary 
excretion (no 
quantitative data). 
 
 (Knoefel et al., 
1932) 
 
In vivo. 
Rats dosed i.p. 
Rabbits dosed by 
gavage. 
 
      (Knoefel, 1934)  
Diethoxymethane (DEM) 
[06.064] 
 
In vivo 
 in rabbits dosed by 
gavage. 
    Considerable amounts 
excreted by pulmonary 
excretion (no 
 (Knoefel et al., 
1932) 
FGE.03 
                                                     
 
14 Extent of metabolism was determined from recovery of reducing equivalents in expired air and urine. No distinction was made between paraldehyde and acetaldehyde or other possible metabolites. If it is assumed that all primary metabolites / 
hydrolysis products are rapidly converted to endogenous intermediates and carbon dioxide, pulmonary and urinary excretion may reflect excretion of unchanged parent compound. The pulmonary excretion was studied up to the detection limit. 
Urinary excretion was studied for up to 24 hours after cessation of pulmonary excretion. In normal dogs pulmonary excretion lasted for 12 - 26 hours and comprised about 98 % of the total amount recovered. 
15 Estimates for the total extent of metabolism are based on the assumption that paraldehyde is eliminated either by exhalation or by metabolic conversion. No acetaldehyde could be detected in the expired air. 
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TABLE III.1        
Name 
FL-, JECFA-no 
Structure 
Test System Results Hydrolysis Vmax Km Reference Evaluation 
status T½ % Hydrolysis 
(after hours) 
Chemical Enzymatic 
in vivo//in vitro 
O O  
 
quantitative data). 
 
In vivo. Rats dosed i.p. 
Rabbits dosed by 
gavage. 
     Rate constant for 
acid hydrolysis in 
vitro (system not 
known)  
0.00234. 
(Knoefel, 1934)  
1,1-Dimethoxyethane (DME) 
[06.015], 940 
 
O
O  
 
In vivo in rabbits dosed 
by gavage. 
 
    Considerable amounts 
excreted by pulmonary 
excretion (no 
quantitative data). 
 
 (Knoefel et al., 
1932) 
JECFA 
(JECFA, 
2002b) 
CoE Cat. A 
(CoE, 1992) 
In vivo  
Rats dosed i.p. 
Rabbits dosed by 
gavage. 
     Rate constant for 
acid hydrolysis in 
vitro (system not 
known). 
 
(Knoefel, 1934)  
Dimethoxymethane (DMM) 
[06.074] 
 
O O
 
 
In vivo in rabbits dosed 
by gavage. 
 
    Considerable amounts 
excreted by pulmonary 
excretion (no 
quantitative data). 
 
 (Knoefel et al., 
1932) 
FGE.03 
In vivo.  
Rats dosed i.p. 
Rabbits dosed by 
gavage. 
     Rate constant for 
acid hydrolysis in 
vitro (system not 
known) 
0.00038. 
(Knoefel, 1934)  
Di-(1-propoxy)methane (D1PM) 
(1,1-dipropoxymethane) 
 
O
O  
 
In vivo.  
Rats dosed i.p. 
Rabbits dosed by 
gavage. 
     Rate constant for 
acid hydrolysis in 
vitro (system not 
known) 
0.00360. 
(Knoefel, 1934)  
Di-(2-propoxy)methane (D2PM) 
(2,2-dipropoxymethane) 
 
O
O
 
 
In vivo.  
Rats dosed i.p. 
Rabbits dosed by 
gavage. 
     Rate constant for 
acid hydrolysis in 
vitro (system not 
known) 
0.01810. 
(Knoefel, 1934)  
Di-(1-butoxy)methane (DBM) 
(1,1-dibutoxymethane) 
 
In vivo.  
Rats dosed i.p. 
Rabbits dosed by 
     Rate constant for 
acid hydrolysis in 
vitro (system not 
(Knoefel, 1934)  
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TABLE III.1        
Name 
FL-, JECFA-no 
Structure 
Test System Results Hydrolysis Vmax Km Reference Evaluation 
status T½ % Hydrolysis 
(after hours) 
Chemical Enzymatic 
in vivo//in vitro 
O
O  
gavage. known) 
0.00358. 
1,1-Diethoxypropane (11DEP) 
[06.069], 
 
O
O
In vivo.  
Rats dosed i.p. 
Rabbits dosed by 
gavage. 
      (Knoefel, 1934) FGE.03 
2,2-Diethoxypropane (22DEP) 
 
O
O  
 
In vivo.  
Rats dosed i.p. 
Rabbits dosed by 
gavage. 
     Rate constant for 
acid hydrolysis in 
vitro (system not 
known) 
33,800.0. 
(Knoefel, 1934)  
2,2-Diethoxyethanol (DEOH) 
 
O
O
HO
 
 
In vivo.  
Rats dosed i.p. 
Rabbits dosed by 
gavage. 
      (Knoefel, 1934)  
1,1,2-Triethoxyethane (TrEE) 
 
O
O
O
 
 
In vivo.  
Rats dosed i.p. 
Rabbits dosed by 
gavage. 
      (Knoefel, 1934)  
1,1,2,2-Tetraethoxyethane (TeEE) 
 
O
O
O
O  
 
In vivo.  
Rats dosed i.p. 
Rabbits dosed by 
gavage. 
      (Knoefel, 1934)  
Triethoxymethane (TEM) 
[06.096],  
 
O O
O
 
 
In vivo.  
Rats dosed i.p. 
Rabbits dosed by 
gavage. 
     Rate constant for 
acid hydrolysis in 
vitro (system not 
known) 
7,800.0. 
(Knoefel, 1934) FGE.03 
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Hydrolysis study on acetals formed from aliphatic aldehydes and monoalkyl ethers of ethylene glycols 
(Sokolowski and Burczyk, 1979). 
The group of substances studied can be described by the general formula: RCH[O(CH2CH2O)WR1]2  , 
where R = H, CH3, C2H5, n-C3H7, n-C4H9, n-C5H11; W = 1, 2, 3, 4; and R1 = CH3, C2H5, n-C3H7, n-
C4H9;  
The hydrolysis study was performed in aqueous solutions of 1 M HCL at 20°C and 50°C, respectively. 
TABLE III.2    
Chemical Structure Test System Results 
T½
Reference 
HCH(OCH2CH2OCH3)2 1M HCl, 50°C ~ 20 min  (Sokolowski and Burczyk, 
1979) HCH(OCH2CH2OC2H5)2 1M HCl, 50°C ~ 20 min 
HCH[O(CH2CH2O)2CH3] 2 1M HCl, 50°C ~ 10 min 
HCH[O(CH2CH2O)2C2H5] 2 1M HCl, 50°C ~ 14 min 
HCH[O(CH2CH2O)2 C3H7] 2 1M HCl, 50°C ~ 12 min 
HCH[O(CH2CH2O)3CH3] 2 1M HCl, 50°C ~ 6 min 
HCH[O(CH2CH2O)3C2H5] 2 1M HCl, 50°C ~ 12 min 
HCH[O(CH2CH2O)3C4H9] 2 1M HCl, 50°C ~ 6 min 
HCH[O(CH2CH2O)4CH3] 2 1M HCl, 50°C ~ 6 min 
CH3CH(OCH2CH2OCH3)2 1M HCl, 20°C ~ 27 min 
n- C4H9CH(OCH2CH2OCH3)2 1M HCl, 20°C ~ 17 min 
CH3CH[O(CH2CH2O)2CH3] 2 1M HCl, 20°C ~ 19 min 
C2H5CH[O(CH2CH2O)2CH3] 2 1M HCl, 20°C ~ 16 min 
n- C3H7CH[O(CH2CH2O)2CH3] 2 1M HCl, 20°C ~ 16 min 
n- C4H9CH[O(CH2CH2O)2CH3] 2 1M HCl, 20°C ~ 14 min 
n- C5H11CH[O(CH2CH2O)2CH3] 2 1M HCl, 20°C ~ 15 min 
CH3CH[O(CH2CH2O)2 C2H5] 2 1M HCl, 20°C ~ 26 min 
C2H5CH[O(CH2CH2O)2C2H5] 2 1M HCl, 20°C ~ 18 min 
n- C3H7CH[O(CH2CH2O)2C2H5] 2 1M HCl, 20°C ~ 17 min 
CH3CH[O(CH2CH2O)2C3H7] 2 1M HCl, 20°C ~ 27 min 
n- C4H9CH[O(CH2CH2O)3CH3] 2 1M HCl, 20°C ~ 17 min 
n- C5H11CH[O(CH2CH2O)3CH3] 2 1M HCl, 20°C ~ 19 min 
n- C4H9CH[O(CH2CH2O)4CH3] 2 1M HCl, 20°C ~ 17 min 
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ANNEX IV: TOXICITY 
Oral acute toxicity data are available for four candidate substances of the present Flavouring Group Evaluation from chemical groups 1, 2 and 4, and for two 
supporting substances evaluated by Council of Europe (CoE, 1992). The supporting substances are listed in brackets. 
TABLE IV.1: ACUTE TOXICITY 
Chemical Name [FL-no] Species  Sex  Route  LD50 
(mg/kg bw)  
Reference  
(1,1-Dipropoxyethane [06.034]) Rat NR Oral 5000 (Opdyke, 1979e) 
(1,1-Dibutoxyethane [06.033]) Rat NR Oral 8790 (Smyth et al., 1954) 
Diethoxymethane [06.064] Rabbit  NR Oral 2600 (Knoefel et al., 1932) 
Dimethoxymethane [06.074] Rat F Oral 7950 (Dow Chemical Company, 1987) 
Rabbit NR Oral 5708 (Knoefel et al., 1932) 
1-Ethoxy-1-hexyloxyethane [06.082] Rat NR Oral 13300 (Kynoch et al., 1978) 
Rat NR Oral 5000 (Moreno, 1980b) 
Triethoxymethane [06.096] Rat NR Oral 7060 (Smyth et al., 1951a) 
 
 
 
TABLE IV.2: SUBACUTE / SUBCHRONIC / CHRONIC / CARCINOGENICITY STUDIES 
No subacute, subchronic, chronic, carcinogenicity toxicity studies are available for any candidate of the present flavouring group evaluation from chemical 
groups 1, 2 and 4 or for supporting substances evaluated by JECFA at the 57th (JECFA, 2002a) and by CoE (CoE, 1992). 
 
TABLE IV.3: DEVELOPMENTAL AND REPRODUCTIVE TOXICITY STUDIES 
No developmental and reproductive toxicity data are available for the candidate substances of the present flavouring group evaluation from chemical groups 1, 
2 and 4 or for supporting substances evaluated by JECFA at the 57th (JECFA, 2002a) and by CoE (CoE, 1992). 
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In vitro mutagenicity/genotoxicity data are available for three candidate substances of the present Flavouring Group Evaluation. 
TABLE IV.4: GENOTOXICITY (IN VITRO) 
Chemical Name [FL-no] Test System Test Object Concentration 
 
Result Reference Comments 
Dimethoxymethane [06.074] Ames test S.typh. TA98, TA 100 
S.typh, TA 1535, TA 1537, TA 1538 
667-10000 microgram/plate 
667-10000 microgram/plate 
Neg.* / Pos.** 
Neg.*/**  See footnote 
1) 
(Hoechst-
Celanese Corp., 
1989b) 
In compliance with GLP and OECD 
guideline 471 (1983). 
HGPRT assay CHO cells 0.5 to 5 mg/l Neg.*/** 
See footnote 2) 
(Hoechst-
Celanese Corp., 
1990a) 
In compliance with GLP and OECD 
guideline 476 (1984). 
Diethoxymethane [06.064] Ames test S.typh. TA98, TA 100, TA 1535, TA 1537, 
TA 1538 
100-10000 microgram/plate Neg.*/** 
See footnote 3) 
(Cameron, 
1995) 
Quality of studies cannot be evaluated. 
Mouse lymphoma TK assay L5178Y (TK+/TK-) 3000 – 5000 microgram/ml 
250 – 1500 microgram/ml 
Neg.** 
Pos.* 
See footnote 3) 
(Cameron, 
1995) 
Quality of studies cannot be evaluated. 
Triethoxymethane [06.096] Ames test S.typh. TA97, TA98, TA 100 8 – 5000 microgram/plate Neg.*/** 
See footnote 3) 
(Huels, 1992) Quality of studies cannot be evaluated. 
 *With metabolic activation 
**Without metabolic activation 
1) Dimethoxymethane [06.074] (purity not reported) was tested in a bacterial reversion assay (Ames test) with Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and TA1538 with and without exogenous metabolic activation (liver S9 
mix from rats pretreated with Aroclor 1254), following the preincubation method. A dose range-finding experiment was performed with strain TA100 at doses from 10 to 10000 microgram/plate (one plate per dose). The main experiment was 
conducted at five doses from 667 to 10000 microgram/plate. All doses were tested in triplicate. Water was used as solvent. 
Result: A weak positive response was observed with strain TA100 in the absence of microsomal enzymes (2.4-fold maximum increase in revertant colonies in the dose range-finding experiment and 2.1-fold maximum increase in the main study at 
10000 microgram/plate, respectively). A positive response was also observed with strain TA98 in the absence of microsomal enzymes (3.9-fold maximum increase at 10000 microgram/plate). These effects were dose-related. No positive responses 
were observed with any of the other strains and activation conditions. No bacteriotoxicity was observed up to 10000 microgram/plate in the presence and absence of microsomal enzymes. Precipitations were not observed. 
2) Dimethoxymethane [06.074] (purity not reported) was tested in a gene mutation assay at the HPRT locus in the CHO-K1-BH4 Chinese Hamster Ovary (CHO) cell line with and without exogenous metabolic activation (liver S9 mix from rats 
pretreated with Aroclor 1254). A dose range-finding experiment was performed with 10 concentrations from 0.0098 to 5.0 mg/ml. One main experiment was performed with six dose levels from 0.5 to 5.0 mg/ml. Duplicate cell cultures were used for 
each experimental point. Water was used as solvent. 
Result: The test substance produced slight toxicity at concentrations above 1.0 mg/ml in the assays with and without metabolic activation. One treated culture each with and without metabolic activation had a mutant frequency that was statistically 
elevated over the mutant frequencies of the concurrent vehicle control cultures. Adjacent dose levels with similar levels of toxicity showed no indication of a mutagenic response. The significant mutant frequencies were within the normal range for 
background mutant frequency variation which was 0 to 15 x 10-6. The test substance was considered negative for inducing forward mutations at the HPRT locus in CHO cells. 
3) There are data on genotoxicity for diethoxymethane [06.064] and triethoxymethane [06.096]. While diethoxymethane [06.064] is reported to be negative in a bacterial reversion assay (Ames test) it is reported to be positive in a gene mutation 
assay at the TK locus in mammalian cells in the presence of metabolic activation (Cameron, 1995). Triethoxymethane [06.096] is reported to be negative in a bacterial reversion assay (IUCLID data base of the European Chemicals Bureau, 
referring on Huels Report No. AM-92/20, 1992 (unpublished) (Report is not available)). However, from these studies, details are not available with respect to methods and results, respectively. Thus, the quality of these studies cannot be evaluated.
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In vivo mutagenicity/genotoxicity data are only available for one candidate substance of the present Flavouring Group Evaluation.  
TABLE IV.5: GENOTOXICITY (IN VIVO) 
Chemical Name  Test System Test Object  Route Dose Result  Reference  Comments 
Dimethoxymethane [06.074] Micronucleus assay Mouse I.p. 400 – 4000 mg/kg bw Neg. 
See footnote 1) 
(Hoechst-Celanese Corp., 
1990b) 
In compliance with GLP and OECD 
guideline 474 (1983). 
1) Dimethoxymethane [06.074] (purity not reported) was tested in the micronucleus test in bone marrow cells of ICR mice. Based on the results of a previously conducted dose range-finding study, groups of five males and five females were 
exposed to the test substance at doses of 400, 1333, and 4000 mg/kg body weight by intraperitoneal injection (I.P.) (0.9% sodium chloride was used as vehicle). The animals were sacrificed 24, 48 and 72 hours after dosing. Micronuclei were 
scored in 1000 PCEs per animal. The PCE/NCE ratio was determined by scoring the number of NCEs while scoring 1000 PCEs. 
Result: Within one minute of dosing mice at the 4000 mg/kg dose became prostrate with dyspnea and mice at 1333 mg/kg showed uncoordinated movement. Most mice recovered in one hour. The PCE/NCE ratio was reduced in single groups (e.g. 
0.59 at 4000 mg/kg after 24 hours in males), however, the PCE/NCE ratio was not clearly dose-related. The test substance did not induce a significant increase in micronucleated bone marrow PCEs. 
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ABBREVIATIONS 
ADI  Acceptable Daily Intake 
CAS  Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CHO  Chinese hamster ovary (cells) 
CoE  Council of Europe 
DBM  Di-(1-butoxy)methane  
22DED  2,2-Diethoxypropane  
DEE  1,1-Diethoxyethane   
DEEP  1,2-Di[(1'-ethoxy)ethoxy]propane  
DEM  Diethoxymethane  
DEOH  2,2-Diethoxyethanol  
11DEP  1,1-Diethoxypropane  
DDO  8,8-Dimethoxy-2,6-dimethyl-2-octanol  
DME  Dimethoxyethane  
DMM  Dimethoxymethane  
DMPP  1,1-Dimethoxy-2-phenylpropane 
DNA  Deoxyribonucleic acid 
D1PM  Di-(1-propoxy)methane  
D2PM   Di-(2-propoxy)methane  
EC European Commission 
EEMMD 4-(1'-Ethoxy)ethoxymethyl-2-methyl-1,3-dioxolane 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
HPRT  Hypoxanthine phosphoribosyltransferase 
ID   Identity 
IM  Intra muscular 
IOFI  International Organization of the Flavour Industry 
IP   Intraperitoneal 
IR   Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
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LD50  Lethal Dose, 50%; Median lethal dose 
MPD  4-Methyl-2-phenyl-1,3-dioxolane 
MS  Mass spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NAD  Nicotinamide Adenine Dinucleotide  
NADP  Nicotinamide Adenine Dinucleotide Phosphate 
No  Number 
NOAEL No Observed Adverse Effect Level 
NOEL  No Observed Effect Level 
NTP  National Toxicology Program 
PEEP  Potassium 2-(1'-ethoxy)ethoxypropanoate 
PO Peroral 
SCE  Sister Chromatid Exchange 
SCF  Scientific Committee on Food 
SMART  Somatic Mutation and Recombination Test  
TAMDI Theoretical Added Maximum Daily Intake 
TEEP  1,2,3-Tris((1'-ethoxy)-ethoxy)propane  
TeEE  1,1,2,2-Tetraethoxyethane  
TEM  Triethoxymethane  
TMT  2,4,6-Trimethyl-1,3,5-trioxane  
TrEE  1,1,2-Triethoxyethane  
UDS  Unscheduled DNA Synthesis  
WHO  World Health Organisation  
 
  
